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ABSTRACT 
 
Increase in older population is most rapid in developing countries and will have major impact on public 
health. Indian older population is not well described and there is an urgent need to estimate the burden 
of prevalent disease, disability and risk factors. To accomplish this, we established a longitudinal cohort 
study – MILES, in a rural population of older Indians. We enrolled a random sample of 562 men and 
women aged 60+ from rural India. Baseline visit consisted of a comprehensive clinical examination and 
interview. 
We examined the prevalence of CVD and its relationship with traditional CVD risk factors in MILES. CVD 
was defined as a composite of self-reported history of CVD, major ECG abnormality or peripheral artery 
disease (PAD). Prevalence of CVD was 24.6% in men and 25.6% in women. In multivariate analyses 
among men, BMI, hypertension and physical inactivity were associated with higher prevalence of CVD. 
Among women, chewing tobacco, hypertension and physical inactivity were associated with higher 
prevalence of CVD. 
Additionally, we estimated the prevalence and risk factors for mobility disability in MILES population by 
using inability to attempt or complete a 400-meter usual paced walk as a measure of mobility disability. 
Mobility disability prevalence was much higher in women (43.8%) compared to men (27.9%). In men, 
 
 
iv 
knee pain, fair vision, chronic lung disease and greater number of depressive symptoms were associated 
with mobility disability. Among women, waist circumference, depressive symptoms, knee pain, poor 
vision, CVD history and PAD were associated with mobility disability. Mean walking times were high in 
those men (435 seconds) and women (503 seconds) who completed the walk. Higher walking times 
were associated with higher waist circumference, knee pain and use of walking aid in both men and 
women. 
This dissertation has major public health significance. In this dissertation, we identified the rural older 
Indian population to be very frail, and with high prevalence of disease and mobility disability. There is a 
high prevalence of risk factors, low heath awareness and poor health care access. These data indicate 
urgent need for primary prevention measures and increasing availability of treatment to prevent further 
complications.  
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1.0 INTRODUCTION 
 
1.1 Global aging 
Almost all nations in the world are now experiencing a growth in the number of older adults, though 
there is considerable variability. Most developed countries already have relatively high proportions (15% 
– 22%) of individuals >65 years of age. The most rapid increases in the older population are in the 
developing world. Birth rates are also rapidly declining in many countries, including developing countries 
like India, further accelerating the shift toward an aging society [1]. This change towards an aging society 
is unprecedented. The upsurge in proportion of older adults is accompanied by declines in the 
proportion of the young (under age 15).  As per United Nations (UN), by 2050, the number of elderly in 
the world will exceed the number of young people for the first time in history [2]. Several developed 
countries have already witnessed this reversal of relative proportions of old and young by the year 1998. 
This trend is occurring at a faster pace in the youngest age groups. In 1950, about 5% of the world’s 
population was >65 years of age while 13% was <5 years of age. By 2020, individuals who are >65 years 
of age will outnumber children who are <5 years of age [3, 4]. According to a US government report: “An 
Aging World: 2008”, the world population >65 years of age will double from about 506 million in 2008 to 
1.3 billion by 2040, accounting for 14% of the world’s total population [3]. Consistent with this, the UN 
estimates the proportion of older population (60 years and older) to increase to 21% by the year 2050 
[2] (Figure 1). 
 
 
 
1 
Figure 1: Proportion of population 60 years or older: world, 1950-2050 [2] 
  
2 
 Figure 2: Total fertility rate and life expectancy at birth: world, 1950-2050 [2] 
 
These changes in population structure are a direct consequence of a continuous decline in total fertility 
rate and increased life expectancy at birth globally (Figure 2).  
This change in global demography will bring about numerous challenges and opportunities. Population 
aging is a global phenomenon affecting every human being and is not just limited to a particular region 
or sections of the world. However, global averages can conceal the presence of considerable 
heterogeneity both across and within regions. Various countries are at very distinct stages of the 
process of population aging, and the pace of change differs greatly. There are clear differences between 
regions in the number and proportion of older adults. In the year 2000, developed countries had almost 
one-fifth of their population aged 60 or older. This population is expected to reach one-third by the year 
2050 [2]. On the other hand, in the year 2010, only 8 per cent of the population was over the age of 60 
in the less developed countries. However, by the year 2050 older adults will make up almost 20 percent 
of the population in these countries (Figures 3 and 4) [2]. The absolute rise in the number of older adults 
3 
and the change of population dynamics in relation to the working population has a direct bearing on the 
health and socioeconomic equity and solidarity of society. The pace of population aging is much faster in 
developing countries compared to developed countries. As a result, developing countries will have less 
time to adjust to the consequences of this change in population restructuring. Developing countries 
have not encountered such high numbers of older adults in their population and are not fully equipped 
to handle the challenges presented by this change. Additionally, population aging in developing 
countries is taking place at much lower levels of socioeconomic development compared to developed 
countries, leading to further complications.  
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 Figure 3: Population aged 60 or over: world and development regions, 1950-2050 [2] 
 
 
 
Figure 4: Proportion of population aged 60 or over: world and development regions, 1950-2050 
5 
 Figure 5: Distribution of population by broad age groups: world and development regions, 1950-2050 
[2] 
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 Another challenge that is facing the world and particularly the developing nations is the oldest old 
population. The older population is itself aging and the fastest growing age group in the world is the 
oldest old or those aged 80 years or older. The current rate of increase in the population of the oldest 
old is 3.8 percent per year. According to UN estimates, by the year 2050, one-fifth of older adults will be 
80 years or older [2].  
 
 
Figure 6: Average annual growth rate of total population and population aged 60 or over: world, 1950-
2050 [2] 
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1.2 Aging in India 
 
India is the second most populous country in the world with 1.21 billion people in its 2011 census [5]. In 
2011, the 60+ population accounted for 8% of India population (93 million people). According to 
estimates, by the year 2050, the 60+ population will climb and account for 19% (323 million people) of 
the population [3]. The population pyramid of India follows the structure of most of the other 
developing countries by starting out with a conical shape in the middle of the last century and becoming 
rectangular by the year 2050 (Figure 7) [2]. Data from the World Population Prospects from the UN 
show a similar picture of growth in the 65+ years old population, almost till the end of this century [6]. 
Several forces are driving India’s changing age structure, including an upward trend in life expectancy 
and falling fertility. An Indian born in 1950 could expect to live for 37 years, whereas today India’s life 
expectancy at birth has risen to 65 years; by 2050 it is projected to increase to 74 years. Fertility rates in 
India have declined sharply, from nearly 6 children per woman in 1950 to 2.6 children per woman in 
2010. India has also been experiencing a breakdown of the traditional extended family structure; 
currently, India’s older people are largely cared for privately, but these family networks are coming 
under stress from a variety of sources [7]. 
India is in the early stages of establishing government programs to support its aging population. At the 
current burden of disease levels, rising numbers of older people will likely increase demands on the 
health system. Less than 10% of the population has health insurance (either public or private), and 
roughly 72% of healthcare spending is out-of-pocket [8]. The aging population is particularly at risk, as 
the health insurance scheme for the poor covers only those aged 65 or younger [9].  
Older Indians also face economic insecurity; 90% of them have no pension. According to official 
statistics, labor force participation remains high (39%) among those aged 60 and older and is especially 
8 
high (45%) in rural areas [10]. These high participation rates reflect an overwhelming reliance on the 
agriculture and informal sectors, which account for more than 90% of all employment in India. They also 
reflect the inadequacy of existing social safety nets for older people. In addition, more than two-thirds 
of India’s elderly live in rural areas, limiting their access to modern financial institutions and instruments 
such as banks and insurance schemes [7, 11].  
With India in the early stages of a transition to an older society, little is known about the economic, 
social, and public health implications. Developing countries like India have mostly focused on infectious 
diseases as the main health care challenge. However, these trends of a shift to an aging society will lead 
to increases in the burden of physical and cognitive disability and non-communicable diseases, notably 
osteoarthritis and cardiovascular disease (CVD) [12]. Indian health system is poorly equipped to address 
most of these issues associated with this dramatic change in demographics. New institutions and new 
programs must be implemented and evaluated to determine whether the dual goals of providing 
income and health security at older ages can be achieved at affordable budgets. Data on the status of 
older people are needed to analyze population aging and formulate mid- and long-term policies. 
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Figure 7: Population pyramids for India showing percentage of population in different age groups from 
the years 1950, 2000 and 2050 (estimated) [2] 
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 Figure 8: Probabilistic Population Projections: Population age 65 and over (thousands) 
Based on the 2010 Revision of the World Population Prospects [6] 
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1.3 Aging and mobility disability 
 
1.3.1 Introduction 
Mobility can be defined as the ability to move independently in the environment. It is considered one of 
the most important and basic functions of daily life, and is crucial for retaining the capability to fulfill the 
activities of daily living, social functioning, and overall to maintain a good quality of life.  
The most common way to identify mobility impairment is by evaluating the capacity of an individual to 
move around on their own feet, with or without the aid of assistive devices. Presence of limitations or 
difficulties in walking is considered to be mobility disability. The severity of mobility disability can be 
segregated into different levels. Most commonly, limitation in getting around outside the house, 
neighborhood or the community is considered as community mobility disability. Serious mobility 
disability is described as difficulty in the capacity to move around inside the house. The most severe 
form of mobility disability is considered to be the inability to walk completely (Table 1) [13]. 
 
Table 1: Mobility disability according to severity of condition 
 
 
 
Older population has high prevalence and incidence of chronic disease and disability. Data from Centers 
for Disease Control and Prevention from 2009-10 shows that almost 50% of older Americans suffer from 
Arthritis and more than a quarter of them have heart disease (Figure 9)[14].   
Community mobility disability Limitation in getting around outside the house, 
neighborhood or the community 
Serious mobility disability Difficulty in the capacity to move around inside the 
house 
Severe mobility disability Inability to walk completely 
12 
Figure 9: Percentage of US population age 65 and over who reported having selected health 
conditions, by sex, 2009-2010  
Mobility disability is one of the leading health issues in older adults globally and is the cause for poor 
quality of life in this age group [15, 16]. According to data from the Federal Interagency Forum on Aging 
Related Statistics, age-adjusted percentage of chronically disabled Medicare enrollees aged ≥65 years 
has been decreasing over the years. However, in 2009, 41% of the older population still had at least one 
ADL or IADL disability or were institutionalized (Figure 10)[14]. The aging process itself is often 
accompanied by impairments in mobility and gait disturbances. The prevalence and incidence of 
mobility disability can be variable, as several factors can influence the extent and duration for the 
condition. Epidemiologic studies have identified several diseases and disease processes to be related 
with mobility disability, including cardiovascular, musculoskeletal and neurological diseases [13]. 
Mobility disability can be sudden, following an acute and severe disease process, e.g. myocardial 
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(Data are based on a 2-year average from 2009–2010 for civilian non-institutionalized population.
 SOURCE: Centers for Disease Control and Prevention, National Center for Health Statistics, National Health 
Interview Survey) 
infarction, stroke, fractures, etc. More commonly, the process of mobility disability is more gradual and 
progressive, usually as a result of chronic disease or age-related changes in biology and physiology. 
Depending on the main cause, the onset of mobility disability can be acute and catastrophic or gradual 
and progressive, and follow a dynamic pathway characterized by periods of deterioration and 
recuperation [13, 17, 18]. The duration of mobility disability might also vary from a few days (e.g. after a 
fracture) to lifetime (e.g. after a stroke or other chronic conditions). Another variation in estimates of 
mobility disability is due to differences in definitions and methods used to identify the condition (Table 
2). However, regardless of the method or definition used, the estimated prevalence of mobility disability 
is high in community dwelling older adults.  
 
 
 
Figure 10: Percentage of Medicare enrollees age 65 and over with limitations in activities of daily 
living (ADLs) or instrumental activities of daily living (IADLs), or who are in a long-term care facility, in 
2009 
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 Table 2: Definition of disability or poor mobility used in epidemiologic studies according to different 
examinations 
 
  
Examination Definition of disability or poor mobility 
Self-reported measures of disability 
Activities of Daily Living Categorized as Disabled or not disabled: Disabled in the specific domain 
if difficulty in 1 or more tasks 
Categorized in 3 categories: 1 ADL, 2-3 ADLs, >3 ADLs 
More complicated subscales also used in studies 
Instrumental Activities of 
Daily Living 
Categorized as Disabled or not disabled: Disabled in the specific domain 
if difficulty in 1 or more tasks 
Categorized in 3 categories: 1 IADL, 2-3 IADLs, >3 IADLs 
More complicated subscales also used in studies 
SF-36 Physical Functioning 
Subscale (PF-10) 
Scores are standardized to range from 0 – 100, with a mean of 50, 
standard deviation of 10, and higher scores reflecting better function. 
Disability is categorized using specific domains or as a continuous scale. 
Other self-report Inability/ lot of difficulty to walk a quarter/half a mile  
Inability/ lot of difficulty to climb a flight of stairs 
Require personal assistance in 2 or more ADLs 
Objective measures of disability 
Short Physical Performance 
Battery (SPPB) 
Similarly, an SPPB score of <=9 is considered as evidence of limited 
mobility and a score of <=6 relates to more serious mobility disability. 
Usual gait speed (4, 6 or 10 
meters) 
A gait speed of <1 m/s is considered an important cutoff predicting 
future events.  
A gait sped <0.8 m/s predicts more severe disability. 
In prospective studies, a decline in gait speed of 0.1 m/s in one year is 
considered an important cutoff in predicting future mortality. 
Physical Performance Test 
(PPT) 
The total score ranges from 0 (worst performance) to 36 (best 
performance) for the 9-item test. 
Timed up and go test A cutoff of 12 seconds is used in some studies. Sometimes used as a 
continuous measure.   
400 meter walk Mobility disability defined as the inability to complete 400-meter walk 
test within 15 minutes. 
15 
Mobility disability usually has a very subtle and gradual progress and can remain clinically unrecognized 
for several years before it starts to affect daily living activities, including basic self-care. Mobility 
disability research is essential in understanding its effects on quality of life, particularly for older adults. 
The mobility disability process is multifactorial and has discernable and definable causes. The concept of 
disability can be explained as the difficulty or inability to perform functions due to the gap in a person’s 
ability and social/physical environmental demands [19].  One of the most prominent models used to 
conceptualize disability is based on the Nagi framework [20]. According to this model, the disablement 
process starts with pathology at the cellular or tissue level, which leads to impairments. Impairments are 
defined as abnormalities, defects or losses in specific organs or organ systems, e.g. cardiovascular, 
neurological or musculoskeletal systems. This leads to functional limitations, defined as impairments at 
the level of the organism, or restrictions in basic functioning of the individual, e.g. mobility, climbing 
stairs, grasping, etc. Finally, disability is defined as limitations of the individual in performing socially 
defined roles, tasks and activities, e.g. self-care, household management, etc. Most epidemiologic 
studies test functional limitations by using objective measures of physical performance to link 
impairments (e.g. musculoskeletal disease) with disability (e.g. problems with self-care). Figure 9 shows 
the Nagi framework for disability. 
 
  
16 
  
 
 
 
 
Figure 11: Nagi framework for disability 
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1.3.2 Major determinants of mobility disability 
Epidemiologic studies have shown mobility disability to be associated with several factors, including 
single or multiple chronic diseases, health behaviors, lifestyle and other risk factors. However, major 
proportion of mobility impairment is not clearly related to a specific medical condition, and is 
recognized very late in the process to receive adequate medical care. This issue becomes more 
complicated because of the high prevalence of comorbidity in older adults (Table 9).  
Mobility impairment is associated with disorders and diseases or several organs and organ systems in 
the human body. Majorly, impairments in joints, bones and muscles, brain and cardiovascular system 
are the main factors associated with mobility disability [21]. There are many other modifiable or non-
modifiable risk factors that might contribute to mobility disability. Demographic and socioeconomic 
factors, including female sex, older age, lower education and lower income are associated with mobility 
disability [19, 22]. In-home mobility disability increases from 5% at age 65 to 30% at age 85%[13, 22]. 
Smoking, alcohol use, low physical activity and high BMI are considered lifestyle risk factors for disability 
[23]. Some musculoskeletal conditions, including sarcopenia are also highly correlated with declines in 
mobility [13, 24]. Sarcopenia is defined as involuntary loss of muscle mass and strength and is shown to 
be highly associated with mobility disability in several cross-sectional and longitudinal studies. However, 
there are controversies and inconsistencies in defining and measuring sarcopenia, because of the lack of 
an operative definition and standardized methodologies to measure muscle decline. Sarcopenia, in turn, 
is related to many other causal factors, including age-related loss of motor neurons, hormonal 
deficiencies, changes in inflammatory markers, and impaired protein synthesis [25]. Another geriatric 
syndrome, sarcopenic obesity – low muscle mass and obesity, is associated with mobility impairments 
[26]. Several other chronic clinical and subclinical diseases that have an effect on different organs and 
organ systems also contribute to progression of mobility disability, particularly in older adults [13, 19, 
27].  
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Impairment in central nervous system, sensory system and effector outputs can influence balance 
negatively, which is a significant component of mobility [28, 29]. Some studies have shown association 
of cognitive impairment and subclinical brain disorders with mobility in older adults [30]. New studies 
have shown deficiency in vitamin D to play a role in mobility impairment [31, 32].  
A model in Figure 10 shows the effect of multisystem disorders on gait speed.  
Most research indicates that mobility disability is a multifactorial condition, as there is no clear primary 
cause for the condition in majority of the cases [33]. Even though there is no established path for 
treatment yet, the approach for management and prevention of mobility disability will have to be 
multifaceted to be successful. 
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(Modified from: Brach J, Rosano C, Studenski S. Mobility, In: Hazzard WR et al, Principles of Geriatric 
Medicine and Gerontology, 2007 [22].) 
Figure 12: A model showing the effect of multisystem disorders on gait speed  
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Table 3: Major determinants contributing to mobility disability 
 
1.3.3 Assessment of mobility disability in epidemiologic studies 
Mobility disability has been defined in several different ways in epidemiologic studies. Studies have used 
many different qualitative as well as quantitative methods to describe mobility and gait impairments in 
older adults. However, most of the assessments offer relevant and complementary information to 
detect mobility disability, each with its own strengths and limitations.  
 
 
  
Category Determinant 
Demographic factors Older age 
 Female sex 
Socioeconomic factors Lower income 
 Lower education 
Behavioral factors Smoking, alcohol 
 High BMI 
Cardiovascular disorders Stroke 
 Peripheral artery disease 
Musculoskeletal disorders Sarcopenia/ low muscle strength and power/ sarcopenic obesity 
 Osteoarthritis 
 Other bone and joint disorders 
 Fractures 
Neurological disorders Central Nervous System 
 Peripheral Nervous System 
Respiratory disorders  
Vision and hearing disorders  
Other factors Inflammation 
 Hormonal disturbances 
 Low physical activity 
 Cancer 
 Nutritional deficiency (Vitamin D) 
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Table 4: Usual approaches used for assessment of disability in epidemiologic studies 
 
 
 
 
 
 
 
 
 
 
The most commonly used method for detecting mobility problems is self-report. Self-report questions 
on mobility (e.g. difficulty in performing activities of daily living, walking, climbing stairs, etc.) can 
provide clear and evident data on disability [17, 34-36]. These questions are widely used in 
epidemiologic studies, as they are simple, inexpensive and easy to administer. However, there is a lot of 
variability within self-report questions. There are single item questions based on difficulty or 
dependence in mobility. There are many validated questionnaires that assess mobility impairments 
focusing on different levels and severity of disability (e.g. difficulty in walking short or long distances), 
different parts of the body (e.g. lower extremity – walking, or upper extremity – grasping, lifting), and 
several other criteria [13]. The most commonly used questionnaires are Activities of Daily Living (ADLs) 
that has questions about difficulties in bathing, dressing, eating, ambulating, toilet use and continence 
Self-reported measures 
Participant self-report 
Proxy report 
Self-report questionnaires (ADLs, IADLs, SF-36: PF-10, etc.) 
Professional report 
Objective measures 
Short Physical Performance Battery (SPPB) 
Balance tests  
Chair stands 
Usual gait speed 
Physical Performance Test (PPT) 
Writing a sentence 
 Simulated eating 
 Lifting a book and putting it on a shelf 
Putting on and removing a jacket 
Picking up a penny from the floor 
Turning 360 degrees 
50-foor walk test 
Climbing one flight of stairs 
Climbing up to four flights of stairs 
Wearable electronic monitoring (accelerometers, GIS devices, etc.) 
Timed up and go test 
400 meter walk 
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[21, 34-37]; and the Instrumental Activities of Daily Living (IADLs) that has questions about difficulties in 
managing personal finances, taking medication, using a telephone, preparing meals, housekeeping and 
shopping [35, 36, 38]. The Barthel Index of Activities of Daily Living is a variant of the original ADLs and 
uses expanded response options to determine the degree of independence of the individual in 
performing the basic tasks of daily living [39, 40]. Another questionnaire, PF-10 is a 10-question, generic 
outcome measure designed to examine a person's perceived limitation with physical functioning and is a 
subscale within the 36-item Short Form Health Survey (SF-36) [41]. It has questions on difficulties in 
bathing or dressing, lifting or carrying groceries, bending, kneeling or stooping, walking 100 yards, 
walking several hundred yards, walking more than a mile, climbing one flight of stairs, climbing several 
flights of stairs, moderate activities (moving a table, pushing a vacuum cleaner, etc.) and vigorous 
activities (running, lifting heavy objects, participating in strenuous sports). There are several other 
variants of these questionnaires used in epidemiologic studies. 
However, most self-report questionnaires identify an advanced stage of disability, and do not 
discriminate at the level of high physical function. They provide very little information about the physical 
function of higher functioning individuals (ceiling effect) and identify persons whose ability to perform 
basic functions has already been impaired. Therefore, these measures are appropriate as final outcomes 
to understand the effect of impairment on function leading to disability.  
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Table 5: Components of three self-reported questionnaires on physical function (ADLs, IADLs and PF-
10) 
 
As the research in mobility disability has become more advanced, several objective methods of physical 
performance have been developed. These methods range from simple measures of usual short-distance 
gait speed to comprehensive measures of assessment of upper and lower limb function [19]. A 
commonly used test is the Short Physical Performance Battery (SPPB – figure 11) [28, 42]. This test 
consists of a balance, gait speed and chair stand test. The balance test consists of three components – 
side-by-side stands, semi-tandem stands and tandem stands. The gait speed test is a timed 4-meter walk 
at usual pace. The chair-stand test is a timed 5-time repeated chair stands from a sitting position with 
arms folded. Each test is given a minimum score of 0 and a maximum score of 4. While the individual 
performance measure can be used to evaluate specific functional abilities, the scores from each of the 
tests are usually added together to obtain an aggregate or summary score for each participant and used 
to determine mobility disability. This test has been shown to independently predict mobility disability, 
activities of daily living disability, future hospitalization, nursing home requirement and mortality in 
many large epidemiologic studies [28, 42-45].  
Activities of Daily Living Instrumental Activities of Daily 
Living 
SF-36 Physical Functioning Subscale: PF-
10 
Bathing Managing personal finances Bathing or dressing 
Dressing Taking medication Lifting or carrying groceries 
Eating Using a telephone Bending, kneeling or stooping 
Ambulating Preparing meals Walking 100 yards 
Toilet use Housekeeping Walking several hundred yards 
Continence Shopping Walking more than a mile 
  Climbing one flight of stairs 
  Climbing several flights of stairs 
  Moderate activities (moving a table, 
pushing a vacuum cleaner, etc.) 
  Vigorous activities (running, lifting heavy 
objects, participating in strenuous sports) 
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The short distance usual gait speed (4, 6 or 10 meters) alone has also been used in studies and has 
proven to be predictive of many negative health outcomes [16, 30, 46, 47]. Longer distance walking 
tests, including the 400 meters walk, have been included in several studies, as they have also shown to 
predict disability in older adults [13, 23, 45, 48-50]. These tests are not considered substitutive but are 
complementary to short walking tests and other lower extremity examinations, as they can better 
explain the aerobic fitness component and distinguish mobility disability among higher functioning older 
adults [51-53]. Moreover, this measure is associated with measures of subclinical cardiovascular, 
neurological and musculoskeletal conditions [51, 54]. 
Another assessment, the physical performance test (PPT) has been used frequently in many studies. This 
test assesses multiple domains of physical function by observing the performance of timed tasks that 
simulate activities of daily living with varying levels of difficulty [38]. It consists of tasks such as writing a 
sentence, simulated eating, lifting a book and putting it on a shelf, putting on and removing a jacket, 
picking up a penny from the floor, turning 360 degrees, 50-foor walk test, climbing one flight of stairs 
and climbing up to four flights of stairs. There are several variants and shortened versions of this test. 
Each task has a minimum score of 0 and a maximum score of 4. The total score ranges from 0 (worst 
performance) to 36 (best performance) for the 9-item test.  
The timed up and go test is another effective method of assessing mobility and quantifying performance 
in older adults. [44, 55] This test is objective, quick and easy to perform and includes basic mobility skills. 
In this test, the individual is required to get up from a chair, walk 3 meters, turn and sit back down on 
the same chair. Faster completion time indicates better mobility.  
Recent studies have used more sophisticated methods to describe mobility, function and activity using 
wearable electronic monitoring devices, including accelerometers, gait tracking equipment and 
Geographic Information System (GIS) tracking [13]. However, these techniques are still developing and 
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expensive, but do show a lot of promise for future studies and open up more avenues for research in 
this field.  
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 Figure 13: Components of the Short Physical Performance Battery 
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Table 6: Advantages and disadvantages of self-reported measures of disability 
Advantages Disadvantages 
Easy to administer High ceiling effect 
Inexpensive Depend heavily on environment 
Easier in severely disabled  Capture advanced stage of disability 
Better assessment according to 
the individual’s own environment 
  
Difficult to use cross-culturally, across different SES levels, ethnic 
and racial groups 
Difficult to observe deterioration longitudinally if the levels or 
performance are still high 
 
Table 7: Advantages and disadvantages of objective measures of disability 
Advantages Disadvantages 
Identify a whole spectrum of individuals based on 
performance, including higher functioning ones. 
Need more intensive staff training 
  
Identify non-disabled persons at risk of disability More expensive than self-report 
Better indicators of change in functioning over time Need specialized personnel and space 
Better for cross-national, cross-cultural studies, Difficult to measure in severely disabled persons, 
particularly with incident disability in longitudinal 
studies 
Used as endpoints in intervention studies 
Predict future disability, need for long-term care 
and mortality 
 
1.3.4 Consequences of mobility disability 
Loss of mobility is one of the major factors in increasing dependence and decreasing quality of life in 
older adults. Mobility impairments lead to functional disorders, which further result in increased social 
isolation and healthcare expenditure [13, 22].  
Self-reported mobility impairment has been shown to predict disability and mortality in older 
populations from several countries and cultures globally [56]. More importantly, objective measures for 
mobility disability have allowed researchers to explore the early stages of functional decline with more 
precision without adding too much difficulty in implementation. They have allowed the identification of 
older adults who are independent and do not have any overt symptoms of mobility disability, but are at 
risk for developing impairment in the near future. In general, poor performance on these examinations 
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predicts future mobility disability and difficulties in self-care. Of all these measures, short usual pace gait 
speed is the most predictive of incident mobility disability [16, 30, 46, 47, 57, 58]. Several cutoff points 
have been proposed to make the values of all the exams meaningful clinically. A gait speed of <1 m/s 
predicts lower extremity limitations, hospitalizations, falls and death. A gait speed of <0.8 m/s predicts 
more severe disability. In prospective studies, a decline in gait speed of 0.1 m/s in one year led to an 
increase in 5-year mortality rate [16, 59]. Similarly, an SPPB score of <=9 is considered as evidence of 
limited mobility and a score of <=6 relates to more serious mobility disability [60]. In older adults >70 
years of age and without any self-care disability at baseline, the SPPB was shown to be a powerful 
predictor of incident disability in higher-level mobility disability and activities of daily living. Poor 
performance scores also predict future hospitalizations and nursing home placements in several studies 
[28, 43, 45]. Mobility impairment is shown to be risk factor for several geriatric conditions, including 
falls, fractures, cognitive decline, dementia and functional decline. Decreased mobility due to impaired 
mobility leads to further increase in health problems in older adults, including loss of muscle mass and 
strength, and deterioration of other chronic conditions, increasing the risk of institutionalization and 
death. The rates of mobility impairment are higher in women and in long-term care settings. The rates 
almost invariable increase with age among all ethnicities and geographical regions [16, 43, 47, 58, 61, 
62]. 
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1.4 Aging, mobility disability and chronic disease in India 
There is very little and inconsistent data about mobility disability from India. According to the Census 
from 2001, there were a total of 21.9 million (2.13%) disabled people living in India [63]. According to 
estimates from the National Sample Survey (NSS), which uses a nationally representative stratified 
sample to get estimates, the total number of disabled people in India in 2002 was 20.8 million. These 
disabilities included locomotor, hearing, speech, vision and mental disabilities. However, the numbers 
vary too much within specific categories. The estimate of locomotor or mobility disability according to 
NSS was 10.6 million and according to the Census was 6.1 million (0.6%) [63]. These large differences 
were mostly because of difference in definitions and no standardized approach used to arrive at these 
numbers [64]. All estimates are from self-report, but the NSS uses a much broader classification for 
locomotor disability by including persons with paralysis, amputation, deformity, dysfunction of joints 
and dwarfism. In the census, locomotor disability covers the absence of all toes, all fingers, deformity, 
inability to move without aid, and inability to lift and carry any small article [64]. The Census 2011 is 
supposed to include more detailed information on disability for each age group. 
There are very few epidemiologic studies on prevalence and determinants of mobility disability in India, 
especially in the elderly. One of the major factors leading to disability in older adults in India is 
cardiovascular disease (CVD) [65]. CVD is a global problem, but its presence in developing countries has 
been escalating in the last few years. There are numerous factors contributing to this rise, including 
demographic shifts with altered age profiles, lifestyle and diet changes related to rapid urbanization, 
among several others. According to estimates, by 2020, CVD will become the leading cause of morbidity 
and mortality in most developing nations around the world. With advances in healthcare in developing 
countries, the population suffering from CVD is living to be older than ever before, which may 
contribute to an increase in disability in this population.  
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Several techniques have been developed for the early detection of arterial damage that have provided 
important insights into patterns and pathogenesis of cardiovascular disease and possible subsequent 
disability. Ankle-arm index (AAI) is a very convenient and non-invasive method to detect peripheral 
arterial disease (PAD). Electrocardiogram (ECG) provides information on several major and minor 
abnormalities with the heart. In the last few years, carotid artery ultrasound has shown to be an 
important identifier of carotid atherosclerosis and a good predictor of generalized artery wall thickness 
[66]. A composite measure of these non-invasive examinations provides with a very sensitive and 
specific estimate of presence of subclinical CVD [65]. Regular use of AAI or carotid artery ultrasound is 
not very common in India, especially in research. With growing prevalence of CVD in India, there is an 
urgent need to understand the burden of subclinical disease and risk factors. Risk factor modification 
may not only prevent cardiovascular events and mortality, but also can have an impact on reduction and 
delay in disability and improve quality of life in older adults. Studies have shown association of 
subclinical PAD with mobility impairment and lower physical function in elderly with subclinical disease 
[67-69]. Timely detection of subclinical disease may allow for early treatment opportunities leading to 
improved survival, lower disability and better quality of life in older population.  
 
1.4.1 Importance of objective measures of disease and disability 
One of the biggest challenges in measuring health status in most Asian countries and particularly India is 
the unreliability on participant self-report [11]. Self-reported data has several limitations even in more 
developed countries, which has led to the introduction of biomarkers in the measurement protocols of 
most of the European and North American studies and surveys. Health awareness in India is very poor, 
especially in the rural older population that is mostly illiterate and has inadequate healthcare access. 
This population is characterized by widespread undiagnosed disease, including easily diagnosable 
diseases like hypertension and diabetes [9]. Moreover, objectively measured data may indicate 
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preclinical or subclinical disease (e.g. pre-hypertension, pre-diabetes, decline in performance measures, 
mild cognitive impairment, etc.) that can be used to educate the participants about preventive measures 
and treatments.  
 
1.4.2 Aging studies in India 
To our knowledge, there are three large cross-national efforts that have emerged in the past 10 years to 
provide data to address some of the health concerns in older adults. These include a Survey of Health 
and Retirement in Europe (SHARE), modeled on English Longitudinal Study of Ageing (ELSA) and the US 
Health and Retirement study (US HRS) [70]. SHARE is designed to include all 27 members of the EU in 
2008. These projects include surveys of health and disability, but focus on socioeconomic factors related 
to retirement. The INDEPTH project, International Network for the Demographic Evaluation of 
Populations and their Health, includes 37 sites in Africa, Asia and Latin American and is designed to 
provide adult mortality data that is otherwise lacking [71]. The WHO recently launched the Study of 
Global AGEing and Adult Health (SAGE) in 6 countries, including China, Ghana, India, Mexico, Russia and 
South Africa. It is modeled on the SHARE project and will also link to INDEPTH [72]. These studies will 
provide demographic data but are not designed for in depth study of disease prevalence, causes of 
disability or explore mechanisms.  
Another study, the Longitudinal Aging Study in India (LASI), an investigation of the economic, physical 
and social well-being of India’s growing elderly population was started recently, and is a joint effort of 
the Harvard School of Public Health, the International Institute for Population Sciences and the RAND 
Corporation [73]. A pilot study was carried out in 2010 and enrolled 1683 subjects, age >45 years from 4 
states in India. The long-term goal is to enroll nationally representative sample of 30,000 individuals into 
a longitudinal survey on aging, health and retirement. The data collection consists of a household 
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survey, household finances, assets, debts and living conditions, with information on demographics, 
family and social networks, health, health care utilization, work and employment pensions and 
retirement. The clinical examination in LASI is limited to measurements of blood pressure, blood spot 
storage, anthropometrics, gait speed, grip strength, balance, lung function and vision [11].  
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Table 8: Major epidemiologic studies for outcomes of mobility disability in older adults 
Study and authors Study population Functional 
assessments 
Main conclusions 
The Einstein Aging 
study, Verghese et al. 
2006 [62] 
488 70 to 99 years 
old men and 
women 
Predictor – gait 
disorders  
Outcome – 
institutionalization and 
death 
Incidence and prevalence of gait 
disorders are high in community-
residing older adults and are 
associated with greater risk of 
institutionalization and death. 
Established Populations 
for Epidemiologic 
Studies of the Elderly 
(EPESE), Guralnik et al. 
1994 [28] 
5174 71 years and 
older men and 
women 
Predictor – SPPB, ADLs 
Outcome – nursing 
home admissions, 
short-term mortality 
Strong association between 
performance measures and self-
reported disability. Both tests 
were independent predictors of 
mortality and nursing home 
admissions. 
Established Populations 
for Epidemiologic 
Studies of the Elderly 
(EPESE), Guralnik et al. 
1995 [60] 
1122 71 years and 
older, non-disabled 
men and women 
Predictor – SPPB at 
baseline 
Outcome – future 
disability 
SPPB was highly predictive of 
subsequent disability. It may 
identify elderly with a preclinical 
stage of disability who may 
benefit from interventions to 
prevent the development of 
frank disability. 
Established Populations 
for Epidemiologic 
Studies of the Elderly 
(EPESE) and Hispanic 
EPESE, Guralnik et al. 
2000 [43] 
4,588 initially 
nondisabled older 
persons in EPESE 
and 1,946 initially 
nondisabled 
persons in Hispanic 
EPESE 
Predictor – SPPB 
Outcome – ADLs and 
mobility-related 
disability 
SPPB accurately predict disability 
across diverse populations. 
Summary score and the gait 
speed alone allow for the 
estimation of risk of disability in 
community-dwelling 
populations. 
Honolulu Heart 
Program, Rantanen et 
al. 1999 [74] 
6089 45 to 68 year 
old Japanese-
American men 
Predictor – maximum 
hand grip strength 
Outcomes – gait speed, 
chair stand, self-report 
Hand grip strength was highly 
predictive of functional 
limitations and disability 25 years 
later. 
Longitudinal Study of 
Aging, Miller et al. 2000 
[75] 
5151 70 years and 
older US men and 
women 
Predictors – physical 
activity, comorbid 
conditions, levels of 
functional limitations 
Outcome – ADL/IADL 
disability 
Past physical activity is important 
in delaying the onset of 
disability, regardless of severity 
of functional limitations 
AgeD in HOme Care 
project, Landi et al. 
2007  
[37] 
2005 65 years and 
older European men 
and women 
admitted to home 
care programs 
Predictor – physical 
activity 
Outcome – ADL 
Physical activity has an 
independent effect on functional 
autonomy among frail and old 
people 
Randomized control 
trial, Brach et al. 2003 
[57] 
229 50 to 65 years 
old women at 
baseline 
Intervention – walking 
Outcomes – self report, 
physical performance 
test, gait speed 
Significant relation between 
physical activity during a 14-year 
period and current functional 
status 
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Women’s Health and 
Aging Study, Simonsick 
et al. 1998 [76] 
1002 65 years and 
older moderately to 
severely disabled 
women 
Predictor – Social 
interaction 
Outcome – disability  
Physical disability is not 
necessarily socially disabling. 
Evergreen Project, 
Hirvensalo et al. 2000 
[56] 
1109 65 to 84 year 
old Finnish men and 
women 
Predictor – physical 
exercise, mobility 
Outcomes – mortality, 
dependence 
Mobility impairments predicted 
mortality and dependence 
Health, Aging and Body 
Composition Study, 
Cesari et al. 2005 [47] 
3047 70 to 79 years 
old, well-functioning 
men and women at 
baseline 
Predictor – usual gait 
speed 
Outcomes – lower 
extremity limitation, 
death, hospitalization 
Usual gait speed of less than 1 
m/s identifies persons at high 
risk of health-related outcomes 
in well-functioning older people. 
Health, Aging and Body 
Composition Study, 
Cesari et al. 2009 [77] 
3024 70 to 79 years 
old, well-functioning 
men and women at 
baseline 
Predictor – usual gait 
speed 
Outcomes – lower 
extremity limitation, 
death, hospitalization 
Chair stand and standing balance 
performance may be adequate 
substitutes when gait speed is 
unavailable. 
Health, Aging and Body 
Composition Study, 
Newman et al. 2006 
[78] 
3075 70 to 79 years 
old, well-functioning 
men and women at 
baseline 
Predictors – Ability to 
complete long-distance 
corridor walk and total 
performance time 
Outcomes – Total 
mortality, incident 
cardiovascular disease, 
incident mobility 
limitation, and mobility 
disability 
Ability to do the test and 
performance were important 
prognostic factors for total 
mortality, cardiovascular disease, 
mobility limitation, and mobility 
disability 
Health, Aging and Body 
Composition Study, 
Simonsick et al. 2008 
[23] 
3056 70 to 79 years 
old, well-functioning 
men and women at 
baseline 
Predictors – long-
distance corridor walk 
time 
Outcomes – new self-
recognition of mobility 
limitation within 2 
years 
A sizable proportion of elders 
who report no walking difficulty 
have observable deficits in 
walking performance that 
precede and predict their 
recognition of mobility 
limitation. 
Health, Aging and Body 
Composition Study, 
Inzitari et al. 2007 [30] 
2776 70 to 79 years 
old, well-functioning 
men and women at 
baseline 
Predictors – usual gait 
speed 
Outcomes – Digit 
Symbol Substitution 
Test (DSST) 
Gait speed independently 
predicts a decline in DSST after 5 
years. 
Cohort study using data 
from two health care 
systems, Perera et al. 
2005 [79] 
439 65 years and 
older men and 
women 
Predictor – SPPB 
Outcome – death, 
mortality 
A decline in gait speed of 0.1 m/s 
or 1 point in the Short Physical 
Performance Battery within 1 
year increased the subsequent 5-
year mortality rate. 
Estudio de Evaluacion 
Funcional del Anciano 
102 75 years an 
older well-
Predictor – activities of 
daily living, mobility, 
Gait velocity measurement may 
allow detection of healthy 
Table 8 continued 
35 
(EFA) study, Manuel 
Montero-Odasso et al. 
2004 [80] 
functioning men 
and women 
usual gait velocity 
Outcome – 
hospitalization, 
caregiver requirement, 
incident falls 
elderly people at risk for adverse 
events. Assessment of gait 
velocity is enough to predict 
adverse events. 
Pooled analysis from 9 
cohort studies, 
Studenski et al. 2011 
[16] 
34485 65 years and 
older men and 
women 
Predictor – usual gait 
speed 
Outcome – survival 
rates and life 
expectancy 
Survival increased across the full 
range of gait speeds, with 
significant increments per 0.1 
m/s. 
Systematic review of 27 
articles from 1994 to 
2009, Gabor et al. 2009 
[61] 
65 years and older 
men and women 
from several 
different studies 
Predictor – usual gait 
speed 
Outcome – disability, 
cognitive impairment, 
institutionalization, 
falls, and/or mortality 
Gait speed at usual pace was a 
consistent risk factor for 
disability, cognitive impairment, 
institutionalization, falls, and/or 
mortality. 
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2.0 DISSERTATION GOALS 
Even though a majority of Indian older adults live in rural areas, their health needs have been 
neglected. The burden of chronic disease and disability has not been estimated using objective 
measures in this population, which may have led to introduction of biases to these assessments. 
The Mobility and Independent Living in Elders Study (MILES) was established to determine the 
prevalence of chronic disease and disability and to identify their risk factors in older rural Indians.  
The main goals for this dissertation are to describe the concept and design features of MILES and to 
determine the prevalence and risk factors for cardiovascular disease and mobility disability in this 
population.    
Manuscript 1: The design of Mobility and Independent Living in Elders Study (MILES): a rural aging 
cohort in India 
Aim for manuscript 1: The main aim of this manuscript was to describe the concept and design features 
of MILES. 
Manuscript 2: Prevalence and risk factors of cardiovascular disease in rural older Indians: The Mobility 
and Independent Living in Elders Study (MILES) 
Aims for manuscript 2: The first aim of this report was to estimate the prevalence of CVD in rural older 
Indians from the Mobility and Independent Living in Elders Study (MILES), using the self-reported history 
of CVD, major ECG abnormality, PAD and a combined measure of all three measures. The second aim 
was to examine the relationship of CVD with traditional risk factors. 
Manuscript 3: Prevalence and risk factors for mobility disability in rural older Indians: Mobility and 
Independent Living in Elders Study (MILES) 
Aims for manuscript 3: The first aim of the present study was to estimate the prevalence of mobility 
disability in a rural Indian population aged >=60 years from the Mobility and Independent Living in 
Elders Study (MILES), using the 400-meter usual paced walk as the measure of mobility disability. The 
second aim of this study was to determine the risk factors for mobility disability in this population and 
its association with cardiovascular disease. 
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 3.0 MANUSCRIPT 1: THE DESIGN OF MOBILITY AND INDEPENDENT 
LIVING IN ELDERS STUDY (MILES): A RURAL AGING COHORT IN INDIA 
 
 
Tushar Singh, MD, MS1; Jane A Cauley, DrPH1; Pawan Sharma, MD2; Jammy Guru Rajesh, MBBS, MBA2; 
Clareann H Bunker, PhD1; P S Reddy, MD2; Anne B Newman, MD, MPH1 
 
1 Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA 
2 Department of Community Medicine, MediCiti Institute of Medical Sciences, RR District, Andhra 
Pradesh, India 
 
38 
3.1 Abstract 
Background: Demographic increase in the older population is most rapid in developing countries and 
will have major impact on public health. Indian population is not well described, but evidence suggests 
that the current demographic transition provides a unique opportunity to better understand future 
disability. To accomplish this, we established a longitudinal cohort study – MILES, in a rural population of 
older Indians. 
Methods: We enrolled a random sample of 564 men and women aged 60+ from Medchal Mandal region 
in Andhra Pradesh state. Baseline visit consisted of two separate clinic visits for measurements of blood 
pressure, anthropometry, short physical performance battery, 400-meter walk, grip strength, ankle-arm 
index, cognitive examination, peripheral quantitative computerized tomography, knee x-ray, carotid 
ultrasound, blood draw and a comprehensive interview. Annual follow-up visits are planned to collect 
information on incident disability and disease. 
Results: According to data from the first clinic visit, median age of the participants was 66 years (60-92); 
median body mass index, 21.7 kg/m2; median gait speed, 0.67 m/s and median grip strength 17 kg; 55% 
self-reported their health status as fair or poor and 13% reported falling >1 times in past 12 months.  
Conclusion: Data suggest a much frailer population in this cohort compared to US subjects age 66 years. 
MILES will provide estimates of global burden of disease and disability and their risk factors in older 
adults, and findings from the study will be used to identify potential interventions to prevent disability 
appropriate in this rural population of Indians. 
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3.2 Why was the cohort set up?  
Most developed countries already have relatively high proportions (15% – 22%) of individuals >65 years 
of age, but the most rapid increases in the older population are in the developing world. Birth rates are 
rapidly declining in many countries, including developing countries like India, further accelerating the 
shift toward an aging society [1]. In 1950, about 5% of the world’s population was >65 years of age while 
13% was <5 years of age. By 2020, individuals who are >65 years of age will outnumber children who are 
<5 years of age [3, 4]. This projected increase will be equivalent to a 10-fold increase in the 60+ 
population and a 27-fold increase in the 80+ population globally.  
India is the second most populous country in the world with 1.21 billion people in its 2011 census [5]. In 
2011, the 60+ population accounted for 8% of India population (93 million people). By the year 2050, 
the 60+ population will climb and account for 19% (323 million people) of the population [3]. The 
increase in the 60+ population in India is due to combined effects of fertility decline and increased life 
expectancy [4]. These trends may lead to increases in the burden of physical and cognitive disability and 
non-communicable diseases, notably osteoarthritis, cardiovascular disease (CVD) and diabetes. 
Developing countries like India are ill-equipped to address most of these issues associated with this 
dramatic change in demographics. There is a great need for more detailed data on the prevalence of 
these diseases, their risk factors and consequences, particularly with respect to disability and death in 
developing countries like India.  
The current demographic transition in the Indian population provides a unique opportunity to better 
understand and identify the prevalence, risk factors and develop interventions to prevent the onslaught 
of disability that accompanies non-communicable diseases. We recruited a random sample of older 
adults from a rural region in India to establish a longitudinal cohort study – Mobility and Independent 
Living in Elders Study (MILES), to define the prevalence, incidence and risk factors for disability and age-
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related disease. The main study objectives were to: 1. determine the prevalence of age-related chronic 
disease in older adults; 2. determine the prevalence of socioeconomic, psychosocial, behavioral, dietary 
and environmental risk factors for age-related chronic disease and disability using examinations and 
non-invasive testing; 3. determine which conditions are most strongly associated with mobility disability, 
both cross-sectionally and longitudinally. The rationale for the measures chosen was based on a 
comprehensive model of major common chronic disease and disability, assessed with objective 
measures. This is the description of the concept and design features of the study. 
 
3.3 Setting and sampling frame 
3.3.1 SHARE INDIA/MediCiti Institute of Medical Science (MIMS) 
SHARE India Research Foundation (Science Health Allied Research & Education) is an established 
research institution in Andhra Pradesh, India. It is affiliated with a 500-bed teaching hospital – MediCiti 
Institute of Medical Sciences. One significant research undertaking by SHARE India has been the REACH 
project (Rural Effective Affordable Health Care), established in the year 1995. REACH provides health 
education, immunizations, antenatal care and offers primary to tertiary care for a population of about 
43,270 in 7405 households in 40 villages in the Ranga Reddy district on the northern outskirts of 
Hyderabad, Andhra Pradesh [81, 82]. The REACH Project has enumerated all households in the region 
and mapped each dwelling by GPS. Household information was collected, including self-reported age of 
the residents in the area. This annually updated census was used for the MILES sampling frame.  
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3.4 Who is in the cohort?  
 
3.4.1 Study design and methods 
We designed a 5-year prospective longitudinal cohort study of a representative sample of approximately 
550 men and women (275 each) aged 60 and above from Medchal Mandal region near Hyderabad in 
Andhra Pradesh state in south-central India.  
 
3.4.1.1 Sample size and power 
The sample size of 550 was chosen to accurately estimate the prevalence of common chronic health 
conditions and disability, which are likely to range from 10 – 40%. Additionally, we estimated that we 
would have >80% power to determine risk factors for incidence of mobility disability, defined as inability 
to complete a usual paced 400-meter walk, if 400 participants of 550 were free of disability at the 
baseline examination, thus at risk for an incident event. 
3.4.1.2 Sampling Methodology 
We sampled 10 of 31 villages, and a random sample of households with at least one person aged 60 
years or over in each village. Recruitment continued in each village from a random ordered list until the 
goal for men and women was reached.  
There are 40 villages in the Medchal mandal (similar to a county) with a total population of 49,792. Of 
these, 6737 persons were of age >60 years, as of July 2, 2011 (source REACH database). Seven villages in 
which the age eligible population was less than 30 were excluded. Two villages that were used for an 
Indian Council of Medical Research (ICMR) funded research project on older adults were also excluded. 
Thus, the final sampling frame consisted of 31 villages. Ten villages were selected by probability 
proportion to population size method at the first stage. The number of respondents to be recruited from 
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each of the 10 villages was calculated as proportional to the number of adults age 60 and above in the 
village.  
A random number generator was used to assign a random number to each household in the village with 
at least one person age 60 or older. The household list was sorted in order of random number. The 
recruitment team consecutively went to each household in the ordered list to recruit until they recruited 
the expected number of respondents from that village. If both husband and wife and any other adult 
member living in the same household were age eligible, all were recruited for the study. Initial age 
eligibility was based on reported age in the 2011 REACH census.  
3.4.1.3 Recruitment process 
 A two-member team went to the village in a SHARE vehicle, accompanied by two community health 
volunteers. Recruitment was conducted 3 days per week (Monday, Thursday and Saturday). The goal 
was to recruit 4 individuals for each day, 5 days a week (from Monday to Friday). A maximum number of 
3 visits were made to each household if the selected household members were not available. Telugu 
translated and IRB approved consent form, recruitment script and eligibility form were developed. 
Individuals who were eligible and agreed to participate were scheduled for the MILES clinic visit. 
3.4.1.4 Eligibility 
Men and women were eligible to participate in MILES if they were aged >60 years according to the 
REACH census and lived in a randomly selected household. Eligibility also included ability to give 
informed consent (functional vision, hearing and cognitive function), no plan to move from the area 
over the next 5 years and no end-stage diseases, such as terminal cancer. 
3.4.1.5 Informed Consent 
The protocol and consent form was approved by the MIMS Ethics Committee and the University of 
Pittsburgh IRB. The consent form was translated into Telugu and back translated into English to ensure 
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comparability. All Indian staff hired to work on MILES were fluent in English and Telugu. All participants 
provided informed consent. The international collaboration between SHARE INDIA and the University of 
Pittsburgh researchers was approved by the Indian Council of Medical Research. 
3.4.1.6 Data Collection 
Baseline assessment for MILES was organized into two clinic visits. The duration of each visit was 
approximately 5 hours. The first visit consisted of a fasting blood draw, measurements of blood 
pressure, anthropometry, short physical performance battery, 400 meter walk, grip strength, ankle arm 
index, ECG, and an interview including questions on demographic information, socio-economic status, 
health behaviors, and self-reported disease and disability. The second visit consisted of a cognitive 
function examination, peripheral quantitative computerized tomography (pQCT) of bone and muscle in 
the upper and lower extremities, knee x-ray, monofilament test for peripheral nerve function, dietary 
questionnaire, event history questionnaire and a carotid ultrasonography. All forms and protocols were 
modeled after major global and US aging studies [29, 83-85].  
Figure 14 shows the recruitment flowchart for the first baseline visit. Table 9 demonstrates the mean 
age of 60+ population in the county, sampled villages, refusals, not-eligible and enrolled participants. 
The data collection and questionnaire plan are summarized in Tables 10 and 11.  
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 Figure 14: Recruitment flowchart for MILES 
Total 60+ county population = 
3541 (men = 1618, women = 
1923) 
Total 60+ population in 10 
selected villages = 1598 (men = 
716, women = 882) 
Screened eligible = 826 (men = 
379, women = 447) 
Not contacted due to exceeding 
goal = 662 (men = 295, women 
= 367) 
Refused = 264 (men = 98, 
women = 166) 
Screened ineligible = 59 (men = 
22, women = 37) 
Could not be contacted = 51 
(men = 20, women = 31) 
Not available >=3 times = 
32 (men = 11, women = 21) 
 
Deceased/ moved = 19 
(men = 9, women = 10) 
 
Enrolled = 562 (men = 281, 
women = 281) 
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Table 9:  Mean age of 60+ population in the county, sampled villages, refusals, not-eligible and 
participants enrolled in the study 
Level of Sampling Mean age (total 
population>= 60) 
Mean age 
(>= 60 Men) 
Mean age  
(>= 60 Women) 
40 villages (total county) 68.6 68.6 68.6 
31 villages (sample universe) 68.6 68.6 68.5 
10 villages (selected) 68.4 68.4 68.5 
Approached individuals 68.2 68.1 68.2 
Underwent eligibility 68.2 68.2 68.2 
Eligible respondents 67.8 68.0 67.6 
Not-eligible respondents 73.7 70.6 75.5 
Enrolled respondents 67.6 67.9 67.3 
Refused respondents 68.3 68.3 68.3 
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3.5 What has been measured? 
3.5.1 Components of MILES evaluation 
Table 10: Components of MILES baseline evaluation 
Measurement Category Data points, procedures and instruments 
First clinic visit 
Interviewer administered questionnaires 
General characteristics • Age, religion, caste
Socioeconomic and lifestyle • Marital status
• Education
• Occupation
• Work activity
• Living arrangement
• Household possessions
• Income and expenditure
• Healthcare access
Medical history (self-report of a 
health professional’s diagnosis of 
health conditions) 
• Osteoarthritis/ Rheumatoid arthritis
• Stroke
• Hypertension
• CABG/ angioplasty
• Myocardial infarction
• Angina [86]
• Rheumatic heart disease
• Diabetes
• Chronic pulmonary disease, asthma
• Depression (Geriatric Depression Scale – GDS) [87].
• Vision problems, cataract
• Hearing problems
• Number of teeth in the mouth
• Falls, fractures and other injuries
• Cancer
• Cervical cancer and breast cancer screening questions (women)
• Urinary incontinence (women)
• Prostate health (men)
• Infectious conditions
Disability • Overall health
• Problems with work or activity due to physical health
• Pain that interfered with normal activities
• Problems with memory
• Problems with work or activity due to emotions
• Sleep and fatigue
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• Difficulty with activities of daily living 
Tobacco and alcohol use • Smoking history, type, frequency, quantity and duration 
• Exposure to tobacco smoke 
• Chewing tobacco use 
• Alcohol use history, type, frequency and quantity 
• Other substance abuse 
Weight and weight loss • Weight and weight loss history 
Cooking, water and food security • Type of cooking fuel 
• Exposure to smoke from cooking fuel 
• Source of water used for cooking and drinking 
• Water storage 
• Food security 
Physical activity • Walking/ bicycling for daily work/ activities 
• Exercise frequency and duration 
• Time spent sitting or reclining 
Pain/ stiffness • Knee pain, back pain or any other joint pain 
• Joint stiffness or swelling 
Medication inventory • Type, name and duration of physician prescription, non-
physician prescription, and over-the-counter medications taken 
in the last 14 days 
• Information on alternative medication use, including ayurvedic 
and homeopathic preparations 
Physical examination 
Fasting blood sample • Lipid Profile (total cholesterol, HDL, LDL, triglycerides) 
• Fasting blood sugar 
• Complete blood count, including hemoglobin and hematocrit 
Anthropometry • Height 
• Weight 
• Waist and hip circumference 
Blood pressure and heart rate • Resting blood pressure and heart rate measured thrice in seated 
participants after an initial resting period of 5 minutes using an 
Omron 705 automatic BP machine (Omron Healthcare, Inc., Lake 
Forest, IL).  
• Average of all three measurements was taken for analysis.  
• Hypertension defined as self-reported and use of anti-
hypertensive medication or by the measured blood pressure 
categorized according to the JNC 7 criteria [88] 
Physical performance 
Short Physical Performance 
Battery (SPPB) [28] 
• Balance tests 
• 4 meter usual paced walk 
• Chair stands 
400-meter walk  [85]  
Grip strength  [25] • Hand grip strength was measured to assess upper body skeletal 
muscle function using Jamar handheld dynamometer (Lafayette 
Instrument, Lafayette, IN) 
Cardiovascular examination 
Table 10 continued 
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Electrocardiogram (ECG) • Standard 12-lead resting electrocardiograms were obtained 
using GE MAC 600 (GE Healthcare) machine and were read by a 
physician and classified into major and minor ECG abnormalities 
[89]. 
Ankle-Brachial Index (ABI) • ABI is the ratio of ankle to brachial systolic blood pressure and is 
<0.9 when there is obstruction to blood flow from 
atherosclerosis. ABI is a sensitive and specific measure of lower 
extremity peripheral artery disease. A handheld 8-megahertz 
Doppler probe with built-in speaker, and an OMRON 705 
automatic BP machine was used to measure ankle and brachial 
blood pressure [90]. 
Second clinic visit 
Carotid artery ultrasonography • Carotid artery ultrasonography was used to measure common 
carotid intima-media thickness and plaque number and size in 
the left and right common carotid arteries using Terason T3000 
ultrasound machine with a 12L5 probe set to 8 MHz frequency 
[66, 91]. 
Cognitive function examination  
[92] 
• Translated version of the Hindi Mental State Examination 
(HMSE), which is a modified version of the Mini Mental State 
Examination (MMSE).  
• Word List Learning, Recall, and Delayed Recognition Tests.  
• Object Naming Test.  
• Verbal Fluency Test. 
Peripheral quantitative 
computed tomography (pQCT) 
• pQCT uses low intensity radiologic beams to measures bone 
strength, quality and skeletal muscle area and fat infiltration.  
• The distal radius and distal tibia were scanned using the 
STRATEC XCT 2000L machine (Stratec Medizintechnik GmbH, 
Pforzheim, Germany).  
• The images will be read by a single center using specialized 
software. Standard protocols were followed [93].   
Bilateral fixed flexion knee 
radiograph 
• Knee osteoarthritis is a very common disease in older adults and 
is poorly captured by questionnaires.  
• Radiographs of both right and left knees were acquired using the 
Osteoarthritis Initiative (OAI) protocol.  
• Articular cartilage thickness measured indirectly by radiographic 
joint-space width was used to assess osteoarthritis of the knee.  
• To reduce variability due to image acquisition, the SynaFlexer 
(CCBR-Synarc, Newark, CA) positioning frame and phantom were 
used.  
• The images were read by a clinical radiologist using a Kellgren-
Lawrence scale protocol [94, 95]. 
Monofilament test • Monofilaments were used to evaluate the presence or absence 
of normal light touch sensation, an indicator of the state of 
peripheral nerve function [96]. 
Dietary questionnaire • A mix of closed and open- ended questions were used to 
capture questions on meal pattern, frequency of consumption, 
Table 10 continued 
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Table 11: Components of MILES annual follow-up contact 
 
 
 
 
 
 
 
 
 
 
3.5.2 Training and quality control 
Training and certification were required for all MILES staff before the start of the study. MILES staff 
underwent three weeks of training with clinic staff from the Center for Aging and Population Health, 
University of Pittsburgh. Training included review of examination protocols, practice with data form 
completion and instruction in standardized interviewing strategies. Certification required 
documentation of practice sessions with observation by an expert staff member using a step-by-step 
checklist. Retraining and recertification was conducted periodically and at least every 6 months. Training 
and certification for carotid ultrasonography were provided by technicians from the Ultrasound 
Research Lab (URL) at the University of Pittsburgh.  
food intake changes over the last one year, as well as trying to 
identify symptoms associated with food intake.  
Health events questionnaire • Questions on health events since the last study visit. 
Measurement 
Questionnaires 
   General Health and Function 
   Physical Activity/Sleep 
   Health events 
Anthropometry 
   Height  
   Weight 
Blood Pressure 
Heart Rate 
Short Physical Performance Battery 
400 Meter Walk 
Grip Strength 
Medication Inventory 
Blood Draw 
   Fasting Blood Glucose 
   Hemoglobin 
Table 10 continued 
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Data quality was assessed through periodic inter- and intra-technician review for carotid 
ultrasonography, pQCT and knee x-ray. Annual recertification of all MILES staff was required to ensure 
that they have not deviated from MILES protocol and MOP, and standardization has been maintained. 
Quality was also ensured by random checks of data at regular intervals. All equipment was calibrated 
frequently to ensure proper functioning. 
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3.6 What has it found? Key findings and publications 
Table 12: Demographic characteristics of MILES cohort at baseline 
 Characteristics Men (n=281) Women (n=281) 
Age (years), median (range) 66 (60-90) 65 (60-92) 
Marital status 
Currently married, N (%) 253 (90.4) 109 (38.8) 
Widowed, N (%) 26 (9.3) 169 (60.1) 
Divorced/separated/abandoned, N (%) 1 (0.3) 3 (1.1) 
Schooling (any level), N (%) 132 (47.1) 24 (8.5) 
Currently working, N (%) 123 (43.9) 64 (22.8) 
Table 13: Health and function measures of MILES cohort at baseline 
 Characteristics Men (n=281) Women (n=281) 
Health status (self-reported) 
Good, N (%) 134 (47.9) 118 (42.0) 
Fair, N (%) 144 (51.4) 120 (42.7) 
Poor, N (%) 2 (0.7) 43 (15.3) 
BMI (kg/m2), mean (range) 21.4 (13.6-33.1) 23.1 (14.3-43.7) 
Fallers (in the last 12 months), N (%) 24 (8.6) 47 (16.7) 
Diabetes, N (%) (self-reported) 34 (12.14) 43 (15.30) 
Diabetes, N (%) (self-reported and/or FBS>125) 45 (16.07) 65 (23.30) 
CVD history, N (%) (self-reported) 28 (10.0) 16 (5.7) 
Difficulty in walking short distances (self-
reported)  
88 (31.4) 167 (59.4) 
Difficulty in walking long distances (self-
reported)  
203 (72.5) 222 (79.0) 
Gait speed (m/s), median (IQR) 0.74 (0.59-0.85) 0.61 (0.49-0.72) 
Grip strength (kg), median (IQR) 19.5 (16.0-23.5) 12.0 (9.5-16.5) 
SPPB score, median (IQR) 9 (7-11) 8 (5-9) 
BMI = Body Mass Index; FBS = Fasting Blood Sugar; CVD = Cardiovascular Disease; IQR = Inter quartile range; SPPB 
= Short Physical Performance Battery 
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In this cohort of rural older Indians, there were important differences in the health profiles between 
men and women (Tables 12 and 13). At a similar median age, women had worse function and more 
chronic health conditions compared to men. More than 90% of the men were married, but the majority 
(>60%) of the women were widowed. Almost half of the men had some level of schooling, whereas only 
8.5% of the women had any formal education. Women were slightly heavier with a mean BMI of 23.1 
compared to a BMI of 21.4 in men. Women also had a higher prevalence of diabetes and reported more 
difficulty in walking short and long distances in comparison with men. Further analysis of this rich 
dataset will help validate these rates by comparison of self-report to objective measures. 
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3.7 What are the main strengths and weaknesses?  
MILES is novel and important in several ways, most notably in its extensive characterization of health, 
disease, and physical and cognitive function in a population based random sample of older adults from 
rural India. The data from the study will enable us to analyze many important health issues facing this 
neglected population. The study incorporates a mix of subjective and objective measures, which will 
enable us to assess clinical and subclinical disease, and function in this population. The longitudinal data 
will provide us with incidence and risk factors for morbidity, disability and mortality in older Indians.  
State of the art techniques and internationally valid methods were used in MILES to quantify the burden 
of disease and disability. To our knowledge, 400-meter walk has not been used in studies in India, and 
the use of carotid intima-media thickness to identify subclinical disease has been very limited. The same 
is true for peripheral quantitative computerized tomography (pQCT). The addition of the ABI and carotid 
intima-media thickness (IMT) to make a composite subclinical CVD measure to study the Indian 
population is novel. Standardized measures used in epidemiological studies worldwide were used in 
MILES, to enable comparison of these findings from India with other populations in future. To our 
knowledge, there are no cross-national comparative studies using all these measures in an older Indian 
population.  
There were several limitations in the study. The recruitment for MILES reflected they study goal of 
recruiting committed individuals who agreed to be followed-up over a period of five years. Therefore, 
the generalizability of the study was limited in favor of internal validity. Pulmonary function test using 
spirometry was planned to be included in the study initially, but was not performed due to technical 
challenges. A food frequency questionnaire was considered but was too time consuming for the study 
participants at the baseline visit, which was already very long.  
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Despite the substantial progress in improving our understanding of aging, and age-related disease and 
disability in the developed world, there is very little known about the disease processes, risk factors and 
impact of aging and disease on disability and mortality in older Indian population. Yet, the bulk of future 
disease and disability burden will be in developing countries like India. The scant literature about Indian 
health comes primarily from urban settings yet 70% of the Indian population is rural [5]. In Asian 
populations, there are important biological differences in age-related chronic disease with differences in 
risk factors and potential differences related to genetic factors as well [9]. For example, rates of 
cardiovascular disease and diabetes in Indians are high, even at lower prevalence of obesity compared 
to some developed countries. Thus, it is important that each region of the world conduct studies to 
identify the factors that are unique to that region. 
To our knowledge, there are three large cross-national efforts that have emerged in the past 10 years to 
provide data to address some of the health concerns in older adults. These include a Survey of Health 
and Retirement in Europe (SHARE), modeled on the English Longitudinal Study of Ageing (ELSA) [97] and 
the US Health and Retirement study (US HRS) [70]. SHARE is designed to include all 27 members of the 
EU in 2008. These projects include surveys of health and disability, but focus on socioeconomic factors 
related to retirement. The INDEPTH project, International Network for the Demographic Evaluation of 
Populations and their Health, includes 37 sites in 19 countries in Africa, Asia (including India) and Latin 
American and is designed to provide adult mortality data that is otherwise lacking [71]. The WHO 
recently launched the Study of Global AGEing and Adult Health (SAGE) in 6 countries, including China, 
Ghana, India, Mexico, Russia and South Africa. It is modeled on the SHARE project and will also link to 
INDEPTH [72]. These studies will provide demographic data but are not designed for in depth study of 
disease prevalence, causes of disability or explore mechanisms.  
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Another study, the Longitudinal Aging Study in India (LASI), an investigation of the economic, physical 
and social well-being of India’s growing elderly population was started recently, and is a joint effort of 
the Harvard School of Public Health, the International Institute for Population Sciences and the RAND 
Corporation [73]. A pilot study was carried out in 2010 and enrolled 1683 subjects, age >45 years from 4 
states in India. The long-term goal is to enroll nationally representative sample of 30,000 individuals into 
a longitudinal survey on aging, health and retirement. The data collection consists of a household 
survey, household finances, assets, debts and living conditions, with information on demographics, 
family and social networks, health, health care utilization, work and employment pensions and 
retirement. The clinical examination in LASI is limited to measurements of blood pressure, blood spot 
storage, anthropometrics, gait speed, grip strength, balance, lung function and vision [11]. There is no 
assessment of subclinical disease, e.g. CVD, knee osteoarthritis, or state of the art measures of bone or 
muscle. 
MILES is well positioned to characterize the major contributors to disease and disability with long follow-
up. The study will present opportunities for further understanding of disease processes and developing 
interventions, not only in India, but also in other developing and developed countries. The future plan 
for MILES is to continue annual visits to capture incident disease and disability in this cohort of rural 
older Indians. 
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3.8 Can I get hold of the data? Where can I find out more?  
All collected source data are maintained and stored at the study research office, SHARE India. Specific 
proposals for future collaboration, subject to approval of Indian Council of Medical Research would be 
welcome. Further information can be found on the research center website: www.sharefoundations.org 
or through email to P.S. Reddy at reddyps@verizon.net. 
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4.1 Abstract 
Background: Cardiovascular disease (CVD) is a major health problem accounting for 30% of deaths 
globally. Projected increases in the population aged 60+ are greatest in developing countries, including 
India and will lead to increased CVD burden. Hypertension is the most common risk factor for CVD 
worldwide. We examined the prevalence of CVD and its relationship with hypertension and other risk 
factors in a cohort of rural Indians from the Mobility and Independent Living in Elders Study (MILES). 
Methods: MILES is an observational cohort study, which enrolled 562 community dwelling men (N=281) 
and women (N=281), aged 60+ in Andhra Pradesh, India. CVD was defined as a composite of self-
reported history of CVD, major ECG abnormality or peripheral artery disease. Logistic regression was 
used to analyze the association between CVD and risk factors in cross-sectional analyses. 
Results: Prevalence of CVD was 24.6% in men and 25.6% in women. In multivariate analyses among 
men, each standard deviation increase in BMI was associated with 56% increase in the odds of CVD 
prevalence. Hypertension was associated with more than two-fold and physical inactivity with more 
than four-fold higher prevalence of CVD in men. Among women, chewing tobacco was associated with 
almost a three-fold and hypertension and physical inactivity with at least two-fold higher prevalence of 
CVD. Current alcohol use was associated with 55% lower odds for prevalent CVD. Two hundred and 
eighty two participants were hypertensive, but only 161 individuals were on treatment and 77 
individuals of the treated still had uncontrolled hypertension.   
Conclusion: The prevalence of CVD and several key risk factors is substantial among this cohort of older 
rural Indians. A high proportion of women have hypertension, use chewing tobacco and are physically 
inactive, and all these factors are independently associated with higher prevalence of CVD. There is low 
awareness of hypertension and poor treatment optimization in this cohort. These data indicate urgent 
need for primary prevention measures and increasing availability of treatment to prevent further 
complications.  
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4.2 Introduction 
Cardiovascular disease (CVD) is a major global health problem and is estimated to account for about 
one-third of all deaths [98, 99]. According to the World Health Organization (WHO) statistics from 2005, 
of the 58 million deaths from all causes, there were 17.5 million CVD deaths worldwide. This is three 
times the number of deaths caused by major infectious diseases, including tuberculosis, HIV/AIDS, and 
malaria combined [100]. The WHO estimates that by the year 2030, cardiovascular mortality will 
increase to 23.4 million and chronic disease will account for more than three-fourths of all deaths. This 
will be an increase of almost 37% compared to rates from 2004 [98]. More specifically, by the year 2030, 
the leading causes of death globally are predicted to be ischemic heart disease and stroke [98, 99]. 
Research has shown that CVD has is not confined only to the developed world, but is the leading cause 
of mortality in developing countries as well. About 80% of cardiovascular deaths occur in developing 
countries [100]. Similarly, deaths from cerebrovascular events were 5 times higher in developing, 
compared to developed countries [101]. With a rise of global older population, the burden of chronic 
disease, including CVD is predicted to increase. The most rapid increases in the older population are in 
the developing world [1]. This change towards an aging society is unprecedented and will result in even 
more chronic disease.  
India is the second most populous country in the world with 1.21 billion people in its 2011 census [5]. In 
2011, the 60+ population accounted for 8% of India’s population (93 million people). According to 
estimates, by the year 2050, the 60+ population will climb and account for 19% (323 million people) of 
the population [3]. As a result of this demographic shift, India is expected to face a higher burden of 
chronic disease and disability than any other country in the world over the next few decades. Estimates 
from the WHO report on global burden of disease showed age-standardized CVD mortality among older 
adults aged 60 years and above to be 1,978 per 100,000 persons in India, compared to 800 per 100,000 
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in the United States [102]. With rapidly changing lifestyle and dietary habits of Indians leading to 
increase in cardiovascular risk factors, these numbers are predicted to rise further in the near future 
[103, 104].  
Several techniques have been developed for the early detection of arterial damage that have provided 
important insights into patterns and pathogenesis of cardiovascular disease and possible subsequent 
disability. Ankle-brachial index (ABI) is a very convenient and non-invasive method to detect peripheral 
artery disease (PAD) [105]. Electrocardiogram (ECG) provides information on several major and minor 
abnormalities with the heart. These non-invasive examinations can provide a very sensitive and specific 
estimate of the presence of subclinical CVD [65].  
Several research studies have been conducted in the Indian population to determine the prevalence and 
risk factors for CVD. However, the vulnerable older population has been neglected in most of these 
studies. Even though as many as two-thirds of elderly persons in India live in rural areas, the research 
efforts do not represent this population group [106, 107].  
The first aim of this report was to estimate the prevalence of CVD in rural older Indians from the 
Mobility and Independent Living in Elders Study (MILES), using the self-reported history of CVD, major 
ECG abnormality, PAD and a combined measure of all three measures. The second aim was to examine 
the relationship of CVD with traditional risk factors. We hypothesized that traditional CVD risk factors 
would be associated with prevalent disease, independent of potential confounders. 
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4.3 Methods 
 
4.3.1 Population 
The Mobility and Independent Living in Elders Study (MILES) enrolled 562 individuals aged 60 years or 
above from Medchal Mandal in Andhra Pradesh state, India. Equal number of men and women were 
randomly selected after conducting door-to-door recruitment in 10 villages from February 2012 to 
November 2012 to be a part of the study. Age was determined by the self-report from the Rural 
Effective Affordable Health Care (REACH) 2011 census. Eligibility was determined on participants’ ability 
to give informed consent (functional vision, hearing and cognitive function), physical ability to travel to 
the study clinic in a hospital vehicle, no plan to move from the area over the next 5 years and no end-
stage diseases, such as terminal cancer. Eligible participants were scheduled for a clinic visit where a 
written informed consent was obtained and comprehensive interview and clinical examination were 
conducted. A detailed description of the study has been published elsewhere (REF – MILES study design 
paper – Manuscript #1). 
 
4.3.2 Cardiovascular disease 
History of cardiovascular disease was defined as a self-report of a health professional’s diagnosis of 
myocardial infarction or stroke, or a history of angiography or coronary artery bypass graft.  
Standard 12-lead resting electrocardiograms were obtained using GE MAC 600 (GE Healthcare) machine 
and were read by a physician and classified into major and minor ECG abnormalities [89]. Major ECG 
abnormality was defined to include major Q or QS abnormalities, left ventricular hypertension (LVH), 
isolated major ST-T wave abnormality, atrial fibrillation, first degree atrioventricular block, left bundle 
branch block (LBBB), right bindle branch block (RBBB) and intraventricular block of indeterminate type.  
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Ankle brachial index (ABI) is the ratio of ankle to brachial systolic blood pressure and is <0.9 when there 
is obstruction to blood flow from atherosclerosis. ABI is a sensitive and specific measure of lower 
extremity peripheral artery disease. A handheld 8-megahertz Doppler probe with built-in speaker, and 
an OMRON 705 automatic BP machine was used to measure ankle and brachial blood pressure [90]. 
Peripheral artery disease was defined as an ABI of <0.9 or inability to find pulse in the lower extremities.  
Combined cardiovascular disease was defined as a composite of self-reported history of CVD, major ECG 
abnormality or PAD.  
4.3.3 Measurement of risk factors 
Age, male sex, body mass index (BMI), smoking, chewing tobacco, alcohol, total cholesterol, low density 
lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, diabetes, hypertension and 
physical inactivity were considered as traditional risk factors.  
Seca 214 Stadiometer (Seca, Hanover, MD) was used to measure height in centimeters (cm) to the 
nearest millimeter; Seca 813 Digital Scale (Seca, Hanover, MD) was used to measure weight in kilograms 
(kg); and Gulick II tape measure was used to measure the waist circumference in centimeters. Body 
mass index (BMI), calculated as kg/meter2 and waist circumference were examined as continuous 
variables in the analyses.  
Smoking was classified as current, past, or never. Current use of any type of chewing tobacco and 
alcohol was recorded.    
Participants were asked to fast overnight or for at least 10 hours before the clinic visit. This was 
confirmed by collecting information for the time of last meal at the time of the clinic visit. Blood was 
obtained from fasting participants to measure blood sugar, lipids and complete blood count.  
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Participants were asked to bring all prescription and non-prescription medications they had taken in the 
last 14 days. Dosage, frequency and duration were recorded and medications were categorized into 
classes.  
Diabetes was defined as self-report of a health professional’s diagnosis, use of antidiabetic medication 
or a fasting blood glucose level greater than or equal to 126 mg/dL. 
Resting blood pressure was measured thrice in seated participants after an initial resting period of 5 
minutes using an Omron 705 automatic BP machine (Omron Healthcare, Inc., Lake Forest, IL).  Average 
of all three measurements was taken for analysis. Hypertension was defined as a self-report of a health 
professional’s diagnosis confirmed by the use of anti-hypertensive medication or by the measured blood 
pressure categorized according to the JNC 7 criteria [88].  
Physical inactivity was defined as a self-report of not walking 10 minutes or more continuously every 
day. 
4.3.4 Measurement of potential confounders 
Caste, religion, marital status, and schooling or reading ability were examined as potential confounders. 
Number of years of schooling was determined by self-report and reading ability was assessed in 
individuals with 1-5 years of schooling. Information about caste, marital status, religion and current 
working status were collected from the participants. 
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4.3.5 Statistical analyses 
Descriptive analyses were conducted for all variables to assess proportions, means, standard deviations, 
normality, etc. Participant characteristics were compared for men and women using chi-square tests for 
categorical variables and t-tests for continuous variables.  
Prevalence of cardiovascular disease was calculated in the overall sample and in men and women 
separately. Characteristics were compared for individuals with and without cardiovascular disease. 
Bivariate associations between cardiovascular disease and risk factors, including potential confounders 
were examined. Continuous variables were analyzed using standard deviation as a unit. Variables that 
were significant (p<0.25) in the bivariate analyses were included in the multivariate logistic regression 
model in stepwise logistic regression, along with variables that were determined a priori to be important 
based on previously published literature. The final multivariate model included significant (p<0.05) and a 
priori determined variables. All analyses were conducted for the total sample and men and women 
separately. Data were analyzed using Stata 12. 
4.4 Results 
4.4.1 Population characteristics 
Descriptive characteristics for the total sample are shown in Table 14. A total of 562 individuals (281 
men and women each) completed the baseline clinic visit in the study. The median age in men was 66 
years (range 60-90) and in women 65 years (range 60-92). More than 90% of the individuals were Hindu 
and a small number were Muslims and Christians. More than 90% of the men were currently married; 
however, less than half of the women were married. Men and women both had very low level of 
education with 91.5% of the women having had no schooling and only 26.5% of men having either more 
than or equal to 6 years of schooling or reading ability. Most women and men were not currently 
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working. Women were mostly non-smokers, but more than half used chewing tobacco; however, nearly 
half the men were current smokers and one-third were past smokers. More than half the women, but 
only 6% of the men used chewing tobacco. A majority of the men and women were current alcohol 
drinkers. The median BMI was low in both men (21.2 kg/m2) and women (22.5 kg/m2). Even though not 
significantly different, diabetes was more prevalent in women (23.3%) than men (17.9%). More women 
(43.8%) than men (26.4%) were not physically active. About half of both men and women were 
hypertensive.  
4.4.2 Cardiovascular disease 
Table 15 shows the prevalence of cardiovascular disease in men and women. About a quarter of both 
men and women had prevalent cardiovascular disease. Self-reported history of CVD was 10% in men and 
5.7% in women. Equal proportion of men and women (15.7% each) had major ECG abnormality, even 
though the prevalence of abnormality subcategories was different. More than one-third of total ECG 
abnormalities in men were major Q/QS changes and about one-fourth were due to major ST-T wave 
abnormality. Among women, major ST-T wave changes contributed to almost half of the total ECG 
abnormalities, and about a quarter were because of left ventricular hypertrophy. The prevalence of PAD 
was 6.1% in men and 7.1% in women. 
Tables 16, 17 and 18 compare the characteristics of the total sample, men and women with respect to 
prevalent cardiovascular disease. Among men, BMI and systolic blood pressure (SBP) were significantly 
higher in individuals with prevalent CVD compared to the individuals without CVD. The proportion of 
hypertensive, diabetic and physically inactive men were also higher in the group with prevalent CVD. 
Women with prevalent CVD were more likely to have higher SBP, chewed tobacco and were 
hypertensive and physically inactive compared to the group without prevalent CVD.     
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 4.4.3 Bivariate and multivariate analyses 
Tables 19, 20 and 21 show the results of bivariate logistic regression analyses between prevalent CVD 
and other variables in the total sample, men and women respectively. Among men, higher BMI, greater 
waist circumference, not currently working, diabetes, greater number of depressive symptoms, physical 
inactivity and hypertension were associated with higher prevalence of CVD in bivariate analyses. In 
women, chewing tobacco, not being physically active and being hypertensive were associated with 
higher prevalence of CVD. 
Multivariate logistic regression analyses were conducted to ascertain the strength of relationship 
between prevalent CVD and risk factors after adjustments for potential confounders. The final 
multivariate models for the total sample, men and women are shown in tables 22, 23 and 24. In men, 
each standard deviation increase in BMI was associated with 56% increase in the odds of CVD 
prevalence. Hypertension was associated with more than two-fold and physical inactivity with more 
than four-fold higher prevalence of CVD in men. Among women, chewing tobacco was associated with 
almost a three-fold and hypertension and physical inactivity with at least two-fold higher prevalence of 
CVD. Current alcohol use was associated with 55% lower odds for prevalent CVD in women. Age, 
smoking, and lipids were not associated with prevalent CVD in bivariate and multivariate analyses for 
either men or women.  
 
4.4.4 Hypertension medication use and management 
Given a strong association of hypertension with prevalent cardiovascular disease, separate analyses 
were conducted exploring the management of hypertension among individuals on antihypertensive 
medication. Two hundred and eighty two participants were hypertensive, but only 161 individuals were 
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on treatment and 77 individuals of the treated still had uncontrolled hypertension (Figure 15). According 
to the blood pressure measured in MILES clinic, 218 (38.8%) individuals in the full cohort either had 
stage 1 (SBP: 140-159 or DBP: 90-99) or stage 2 (SBP>=160 or DBP>=100) hypertension.  
 
4.5 Discussion 
In this study of rural older Indians, a quarter of the participants were found to have prevalent 
cardiovascular disease and the prevalence was similar in men and women. Self-reported prevalence of 
CVD history was 10% in men and 5.7% in women. These estimates are similar to other studies in India, 
where the self-reported prevalence varies from 2.7% to 15.7% in different studies, settings and age 
groups [108].  
Most major studies have shown men to have higher prevalence of CVD compared to women [109-111]. 
The similar rate of disease in men and women in this study might represent a survival advantage for 
women, with men more likely to have died from coronary heart disease. This possibility is supported by 
observing a much higher proportion of widowed women (60%) compared to men (9%) in the sample. 
The high prevalence of CVD in women can also be due to a two-fold higher rate of non-specific ST-T 
wave abnormality in women compared to men. Similar results have been shown in other major studies 
in older adults [89], but are not fully explained. Previous studies have shown ST-T wave abnormalities to 
be associated with higher risk for future coronary heart disease and mortality in both men and women 
[112, 113]. Men reported higher rates of CVD events in the past and this might explain the higher 
prevalence of Q/QS abnormality in men. These changes may also reflect higher prevalence of 
unrecognized heart disease in men or failure to seek medical care in presence of symptoms.  
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In this study, the prevalence of peripheral artery disease was 6.1% in men and 7.1% in women. These 
estimates are slightly lower than estimates from other studies in low-and middle-income countries, 
which show a prevalence of 5.5-21.5% in men and 8.9-18.7% in women aged 60-99 years [114]. Studies 
have shown association of subclinical PAD with mobility impairment and lower physical function in 
elderly [67, 68, 115]. Timely detection of subclinical disease may allow for early treatment opportunities 
leading to improved survival and mobility, lower disability and better quality of life in older population. 
Age was not associated with CVD in this study. Smoking is an established risk factor for CVD. However, in 
these analyses smoking was not associated with CVD. A majority of the women were using chewing 
tobacco and its use was associated with higher prevalence of CVD. Previous studies have shown similar 
associations of the use of smokeless tobacco with cardiovascular morbidity and mortality [116]. 
In this study, almost half of the participants were hypertensive. This is consistent with other studies of 
hypertension in India [117]. The relationship of hypertension with future cardiovascular disease and 
mortality has been established in studies all over the world previously. However, this study showed a 
low awareness of hypertension, with about half of the hypertensive individuals on medication. 
Furthermore, of these, only half had their hypertension under control. These numbers are better than 
the proportion of treated or controlled hypertensive individuals from several low- and middle-income 
countries, but not as good as some developed countries [118].  
Physical inactivity, another established risk factor for CVD, was associated with higher prevalence of CVD 
in this population. To our knowledge, there are no published studies analyzing the relationship between 
physical activity and CVD in older adults in India. Physical activity is an important modifiable risk factor 
for CVD [119] and more effort is needed to increase awareness about regular physical activity in this 
population. 
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Cardiovascular disease is the leading cause of mortality in the Indian population. Cardiovascular 
mortality has declined in most developed countries in the last few years [120]. However, with an 
increase in life expectancy and higher number of older adults, the cardiovascular mortality has increased 
in several Asian countries, including India [120]. Most of the global decline in cardiovascular mortality 
can be attributed improved treatment and management and reduction of risk factors, including 
hypertension, smoking, and cholesterol [120].  
This study has several strengths. Older Indian rural population has a high burden of cardiovascular 
morbidity and mortality, but there is very limited research conducted in this neglected population. Most 
studies conducted to estimate the prevalence of CVD in this population have used self-report as a 
measure of prevalent disease. Self-reports of diagnosed medical conditions depend on health awareness 
and access to health care, and therefore, can conceal undiagnosed conditions [11, 73, 121]. In 
developing countries like India where access to health care is limited, particularly in rural areas, the 
prevalence of undiagnosed diseases is expected to be higher compared to urban areas or developed 
countries. The addition of objectively measured PAD and ECG to estimate the prevalence of CVD is novel 
in this population and enabled us to have a better estimate of disease. The addition and use of objective 
measures enabled us to eliminate self-report biases that may be differentially associated with health 
awareness or health care access. These objective measures provide additional insights into true disease 
prevalence as well as the extent of undiagnosed and subclinical disease in this population. 
There are a few limitations of the study. The data analyzed in this effort are cross-sectional and causal 
relationships cannot be inferred. This can be particularly true for the relationship between low physical 
activity and CVD where low activity may be a consequence of disease. 
In this study, there is a clear relationship of some of the well-known risk factors for CVD with prevalent 
disease. With growing prevalence of CVD in India, there is an urgent need to understand the burden of 
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clinical as well as subclinical disease and risk factors using studies conducted in India. Risk factor 
modification may not only prevent cardiovascular events and mortality, but also can have an impact on 
reduction and delay in disability and improve quality of life in older adults. Strong public health policies 
are required to not only restrict use of smoking, but also chewing tobacco. Physical activity needs to be 
promoted, particularly among older adults. Improved access to health care, and inexpensive but 
effective medication, is required to combat disease and risk factors, including hypertension. Better 
optimization of treatment is needed for management of diagnosed disease. Good incidence data is 
needed to have better understanding of disease processes in this population, particularly in women.  
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4.6 CVD tables and figure 
Table 14: Descriptive characteristics of all MILES participants at baseline 
 Characteristics Men (N=281) Women (N=281) p-value 
Age (years), median (range) 66 (60-90) 65 (60-92) 0.163 
Marital status     <0.001 
Currently married, N (%) 253 (90.4) 109 (38.8) 
Widowed, N (%) 26 (9.3) 169 (60.1) 
Divorced/separated/abandoned, 
N (%) 
1 (0.3) 3 (1.1) 
Religion   0.514 
              Hindu, N (%) 258 (92.1)  253 (90.0) 
              Muslim, N (%) 11 (3.9) 17 (6.1) 
             Christian, N (%) 11 (3.9) 11 (3.9) 
Caste    0.598 
              Scheduled caste, N (%) 37 (13.2)  48 (17.1) 
              Scheduled tribe, N (%) 17 (6.1) 16 (5.7) 
              Backward caste, N (%) 157 (56.1) 146 (52.0) 
              Other, N (%) 69 (24.6) 71 (25.3) 
Schooling and reading ability, N (%)   <0.001 
No schooling, N (%) 148 (53.1) 257 (91.5) 
<6 years of schooling and not 
able to read, N (%) 
57 (20.4) 11 (3.9) 
>=6 years of schooling or able to 
read 
74 (26.5) 13 (4.6) 
Currently not working, N (%) 157 (56.1) 217 (77.2) <0.001 
Health status (self-reported)     0.163 
Good, N (%) 134 (47.9) 118 (42.0) 
Fair, N (%) 144 (51.4) 120 (42.7) 
Poor, N (%) 2 (0.7) 43 (15.3) 
Weight (kg), median (range) 54.7 (28.9-92.2) 49.4 (28.3-108.7) <0.001 
Height (cm), median (range) 161.2 (141.3-
177.7) 
147.4 (128.0-
162.9) 
<0.001 
BMI (kg/m2), median (range) 21.2 (13.6-33.1) 22.5 (14.3-43.7) <0.001 
Waist circumference (cm), median 
(range) 
83.0 (52.9-112.3) 78.8 (54.7-132.6) 0.004 
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Smoking   <0.001 
                Current, N (%) 121 (43.1) 1 (0.4) 
                Past, N (%) 91 (32.4) 6 (2.1) 
                Never, N (%) 69 (24.6) 274 (97.5) 
Chewing tobacco, N (%) 17 (6.1) 145 (51.6) <0.001 
Alcohol, N (%) 199 (71.1) 161 (57.3) 0.001 
Fasting blood sugar (FBS) (mg/dL), 
median (IQR) 
95 (84-112) 100 (87-116) 0.047 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
50 (17.9) 65 (23.30) 0.112 
Hemoglobin (g/dL), median (IQR) 13.9 (12.4-15.1) 12.4 (11.5-13.1) <0.001 
Total cholesterol (mg/dL), median (IQR) 171.0 (144.5-
199.0) 
195.0 (168.0-
224.0) 
<0.001 
LDL cholesterol (mg/dL), median (IQR) 100.0 (77.0-126.0) 117.5 (96.0-
145.0) 
<0.001 
HDL cholesterol (mg/dL), median (IQR) 45.5 (38.0-54.5) 46.0 (40.0-56.0) 0.026 
Systolic blood pressure (SBP) mmHg, 
median (IQR) 
133.7 (118.0-
153.0) 
130.0 (115.0-
145.3) 
0.021 
Diastolic blood pressure (DBP) mmHg, 
median (IQR) 
72.0 (64.7-80.3) 72.3 (65.7-79.7) 0.834 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
137 (48.8) 143 (50.9) 0.613 
Physically inactive (not walking 10 
minutes continuously every day), N (%) 
74 (26.43) 123 (43.77) <0.001 
  
  
Table 14 continued 
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Table 15: Prevalence of cardiovascular disease in men and women at baseline 
 Men (N=281) Women (N=281) p-value 
CVD history (self-reported), N (%)  28 (10.0) 16 (5.7) 0.058 
Peripheral artery disease, N (%) 17 (6.1) 20 (7.1) 0.626 
ECG abnormality, N (%) 44 (15.7) 44 (15.7) 1.000 
Major Q/QS abnormality, N (%) 15 (5.3) 5 (1.8) 0.023 
LVH, N (%) 5 (1.8) 10 (3.6) 0.191 
Major ST-T wave abnormality, N 
(%) 
10 (3.6) 20 (7.1) 0.061 
Atrial fibrillation, N (%) 2 (0.7) 1 (0.4) 0.563 
First degree AV block, N (%) 5 (1.8) 3 (1.1) 0.476 
LBBB, N (%) 2 (0.7) 2 (0.7) 1.000 
RBBB, N (%) 9 (3.2) 1 (0.4) 0.011 
Intraventricular block 
(indeterminate), N (%) 
1 (0.4) 2 (0.7) 0.563 
Combined cardiovascular disease, N (%) 69 (24.6) 72 (25.6) 0.770 
 
  
74 
Table 16: Characteristics of all MILES participants by combined cardiovascular disease 
 Characteristics With combined 
CVD (N=141) 
Without 
combined CVD 
(N=421) 
p-value 
Age (years), mean (SD) 68.4 (6.8) 67.3 (6.3) 0.076 
Male sex, N (%) 69 (48.9) 212 (50.4) 0.770 
Not currently married, N (%)   47 (33.6) 152 (36.1) 0.587 
Schooling and reading ability, N (%)   0.940 
No schooling, N (%) 100 (71.9) 305 (72.5) 
<6 years of schooling and not able to 
read, N (%) 
18 (12.6) 50 (11.9) 
>=6 years of schooling or able to read 21 (15.1) 66 (15.7) 
BMI (kg/m2), mean (SD) 22.7 (4.7) 22.1 (4.5) 0.210 
Smoking   0.521 
                Never, N (%) 86 (61.0) 257 (61.1) 
                Past, N (%) 28 (19.9) 69 (16.4) 
                Current, N (%) 27 (19.2) 95 (22.6) 
Chewing tobacco 53 (37.9) 109 (25.9) 0.007 
Alcohol 80 (57.1) 280 (66.5) 0.045 
Total cholesterol (mg/dL), mean (SD) 189.0 (48.4) 184.8 (43.2) 0.334 
LDL cholesterol (mg/dL), mean (SD) 112.9 (36.3) 114.2 (49.3) 0.785 
HDL cholesterol (mg/dL), mean (SD) 49.0 (14.4) 47.5 (12.1) 0.205 
Systolic blood pressure (SBP), mean (SD) 141.7 (24.8) 132.0 (23.0) <0.001 
Diastolic blood pressure (DBP), mean (SD) 74.2 (11.2) 72.6 (11.9) 0.153 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
91 (64.5) 191 (45.4) <0.001 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
36 (25.7) 79 (18.9) 0.082 
Physically inactive (not walking 10 minutes 
continuously every day), N (%) 
76 (54.3) 121 (28.7) <0.001 
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Table 17: Characteristics of men by combined cardiovascular disease 
 Characteristics With combined 
CVD (N=69) 
Without 
combined CVD 
(N=212) 
p-value 
Age (years), mean (SD) 68.7 (7.3) 67.7 (6.4) 0.276 
Not currently married, N (%)  4 (5.9) 23 (10.9) 0.227 
Schooling and reading ability, N (%)   0.439 
No schooling, N (%) 31 (46.3) 117 (55.2) 
<6 years of schooling and not able to 
read, N (%) 
16 (23.9) 41 (19.3) 
>=6 years of schooling or able to read 20 (29.9) 54 (25.5) 
BMI (kg/m2), mean (SD) 22.6 (4.0) 21.0 (3.8) 0.004 
Smoking   0.552 
                Never, N (%) 16 (23.2) 53 (25.0) 
                Past, N (%) 26 (37.7) 65 (30.7) 
                Current, N (%) 27 (39.1) 94 (44.3) 
Alcohol 45 (66.2) 154 (72.6) 0.306 
Total cholesterol (mg/dL), mean (SD) 176.3 (40.0) 172.3 (38.4) 0.461 
LDL cholesterol (mg/dL), mean (SD) 106.0 (36.2) 105.8 (55.6) 0.985 
HDL cholesterol (mg/dL), mean (SD) 47.6 (13.4) 46.3 (11.8) 0.446 
Systolic blood pressure (SBP) mmHg, median 
(IQR) 
146.0 (26.1) 133.8 (23.6) <0.001 
Diastolic blood pressure (DBP) mmHg, median 
(IQR) 
74.6 (12.1) 72.6 (12.4) 0.253 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
47 (68.1) 97 (45.8) 0.001 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
18 (26.5) 32 (15.1) 0.033 
Physically inactive (not walking 10 minutes 
continuously every day), N (%) 
34 (50.0) 40 (18.9) <0.001 
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Table 18: Characteristics of women by combined cardiovascular disease 
 Characteristics With combined 
CVD (N=72) 
Without 
combined CVD 
(N=209) 
p-value 
Age (years), mean (SD) 68.1 (6.2) 66.9 (6.2) 0.146 
Not currently married, N (%)   43 (59.7) 129 (61.7) 0.764 
BMI (kg/m2), mean (SD) 22.8 (5.2) 23.3 (4.8) 0.455 
Chewing tobacco 47 (65.3) 98 (46.9) 0.007 
Alcohol 35 (48.6) 126 (60.3) 0.084 
Total cholesterol (mg/dL), mean (SD) 201.1 (52.7) 197.7 (44.2) 0.591 
LDL cholesterol (mg/dL), mean (SD) 119.4 (35.3) 122.7 (40.2) 0.531 
HDL cholesterol (mg/dL), mean (SD) 50.3 (15.2) 48.6 (12.4) 0.333 
Systolic blood pressure (SBP) mmHg, median 
(IQR) 
137.6 (22.8) 130.3 (22.3) 0.018 
Diastolic blood pressure (DBP) mmHg, median 
(IQR) 
73.9 (10.4) 72.6 (11.5) 0.384 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
44 (61.1) 94 (45.0) 0.018 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
18 (25.0) 47 (22.7) 0.692 
Physically inactive (not walking 10 minutes 
continuously every day), N (%) 
42 (58.3) 81 (38.8) 0.004 
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Table 19: Bivariate logistic regression analyses of combined CVD with the total sample 
Odds Ratio 95% confidence 
interval 
p-value 
Age 1.03 1.00–1.06 0.077 
Male sex 0.94 0.65–1.38 0.770 
Caste 
Others 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 0.75 0.47–1.18 0.217 
Scheduled caste/Scheduled tribe 1.01 0.58–1.74 0.984 
Not currently married 0.89 0.60–1.34 0.587 
Schooling and reading ability 
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 1.10 0.61–1.97 0.754 
>=6 years of school or able to read 0.97 0.57–1.67 0.913 
BMI (per SD) 1.13 0.93–1.36 0.211 
Waist circumference (per SD) 1.15 0.95–1.39 0.151 
Smoking 
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.21 0.73–2.00 0.452 
Current smoking 0.85 0.52–1.39 0.516 
Chewing tobacco 1.74 1.16–2.61 0.007 
Alcohol 0.67 0.45–0.99 0.046 
Not working 1.78 1.15–2.75 0.009 
Total cholesterol (per SD) 1.10 0.91–1.33 0.333 
LDL cholesterol (per SD) 0.97 0.80–1.18 0.784 
HDL cholesterol (per SD) 1.13 0.94–1.36 0.206 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
2.19 1.48–3.25 <0.001 
Diabetes 1.49 0.95–2.34 0.083 
Not physically active (not walking 10 minutes 
continuously every day) 
2.94 1.99–4.37 <0.001 
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Table 20: Bivariate logistic regression analyses of combined CVD for men 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.02 0.98–1.06 0.276 
Caste    
Others 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 0.75 0.39–1.44 0.395 
Scheduled caste/Scheduled tribe 0.92 0.41–2.06 0.841 
Not currently married 0.51 0.17–1.54 0.235 
Schooling and reading ability    
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 1.47 0.73–2.97 0.279 
>=6 years of school or able to read 1.40 0.73–2.67 0.311 
BMI (per SD) 1.59 1.16–2.19 0.004 
Waist circumference (per SD) 1.58 1.16–2.14 0.003 
Smoking    
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.33 0.64–2.72 0.444 
Current smoking 0.95 0.47–1.92 0.890 
Chewing tobacco 1.77 0.63–4.98 0.280 
Alcohol 0.74 0.41–1.32 0.307 
Not working 2.08 1.16–3.71 0.014 
Total cholesterol (per SD) 1.13 0.82–1.54 0.460 
LDL cholesterol (per SD) 1.00 0.78–1.28 0.985 
HDL cholesterol (per SD) 1.11 0.84–1.48 0.445 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
2.53 1.43–4.50 0.002 
Diabetes 2.03 1.05–3.91 0.035 
Not physically active (not walking 10 minutes 
continuously every day) 
4.30 2.39–7.73 <0.001 
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Table 21: Bivariate logistic regression analyses of combined CVD for women 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.03 0.99–1.08 0.147 
Caste    
Others 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 0.74 0.39–1.42 0.371 
Scheduled caste/Scheduled tribe 1.08 0.51–2.27 0.846 
Not currently married 0.92 0.53–1.59 0.764 
Schooling and reading ability    
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 0.61 0.13–2.87 0.528 
>=6 years of school or able to read 0.23 0.03–1.78 0.158 
BMI (per SD) 0.91 0.70–1.17 0.454 
Waist circumference (per SD) 0.92 0.71–1.19 0.538 
Chewing tobacco 2.13 1.22–3.71 0.008 
Alcohol 0.62 0.36–1.07 0.085 
Not working 1.46 0.74–2.89 0.270 
Total cholesterol (per SD) 1.07 0.83–1.38 0.590 
LDL cholesterol (per SD) 0.90 0.65–1.24 0.530 
HDL cholesterol (per SD) 1.13 0.88–1.46 0.332 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
1.92 1.11–3.32 0.019 
Diabetes 1.13 0.61–2.12 0.692 
Not physically active (not walking 10 minutes 
continuously every day) 
2.21 1.28–3.82 0.004 
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Table 22: Multivariate logistic regression analyses of combined CVD with the total sample 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.02 0.98–1.05 0.311 
Male sex 1.63 0.81–3.30 0.172 
BMI (per SD) 1.07 0.85–1.34 0.579 
Smoking    
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.18 0.58–2.40 0.647 
Current smoking 1.04 0.49–2.20 0.912 
Chewing tobacco 2.19 1.28–3.75 0.004 
Alcohol 0.63 0.41–0.97 0.036 
Total cholesterol (per SD) 1.39 0.86–2.25 0.179 
LDL cholesterol (per SD) 0.66 0.38–1.16 0.148 
HDL cholesterol (per SD) 1.03 0.81–1.32 0.797 
Diabetes 1.38 0.82–2.34 0.225 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
2.06 1.34–3.15 0.001 
Physically inactive (not walking 10 minutes 
continuously every day) 
2.78 1.83–4.23 <0.001 
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Table 23: Multivariate logistic regression analyses of combined CVD for men 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.03 0.98–1.08 0.249 
BMI (per SD) 1.56 1.06–2.30 0.024 
Smoking    
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.38 0.60–3.16 0.450 
Current smoking 1.25 0.54–2.90 0.609 
Chewing tobacco 1.65 0.48–5.71 0.431 
Alcohol 0.94 0.47–1.86 0.855 
Total cholesterol (per SD) 0.86 0.52–1.41 0.551 
LDL cholesterol (per SD) 1.06 0.71–1.57 0.783 
HDL cholesterol (per SD) 1.10 0.79–1.52 0.576 
Diabetes 1.66 0.74–3.70 0.216 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
2.09 1.11–3.93 0.023 
Physically inactive (not walking 10 minutes 
continuously every day) 
4.03 2.14–7.60 <0.001 
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Table 24: Multivariate logistic regression analyses of combined CVD for women 
Variable Odds Ratio 95% confidence 
interval 
p-value 
Age 1.01 0.96–1.06 0.749 
BMI (per SD) 0.91 0.67–1.25 0.570 
Chewing tobacco 2.71 1.40–5.23 0.003 
Alcohol 0.45 0.24–0.82 0.010 
Total cholesterol (per SD) 1.94 1.03–3.67 0.040 
LDL cholesterol (per SD) 0.44 0.21–0.94 0.033 
HDL cholesterol (per SD) 0.98 0.71–1.36 0.920 
Diabetes 1.34 0.64–2.79 0.442 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
2.03 1.12–3.70 0.020 
Physically inactive (not walking 10 minutes 
continuously every day) 
2.05 1.15–3.65 0.015 
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 Figure 15: Number of individuals with hypertension, using antihypertensive medication and with 
controlled hypertension 
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5.1 Abstract 
Background and Objective: Older population is predicted to increase globally and this increase is most 
rapid in developing countries. Mobility disability is a serious health problem encountered in the elderly, 
causing loss of independence and higher rates of morbidity and mortality. However, there is insufficient 
research from developing countries determining the prevalence of objectively measured mobility 
disability. The purpose of this study was to estimate the prevalence and risk factors for mobility 
disability in a rural Indian population aged >=60 years from the Mobility and Independent Living in 
Elders Study (MILES). 
Methods: MILES is an observational cohort study, which enrolled 562 community dwelling men (N=281) 
and women (N=281), aged >=60 years in rural India. Mobility disability was defined as inability to 
attempt or complete a 400-meter usual paced walk. Logistic regression was used to analyze the 
association between mobility disability and risk factors in cross-sectional analyses. Additional analyses 
were conducted for participants who completed the 400-meter walk, to examine the relationship 
between walk time and risk factors for mobility disability.  
Results: Median age of women (65 years) and men (66 years) were similar. Mobility disability prevalence 
was much higher in women (43.8%) compared to men (27.9%). In men, knee pain, fair vision and chronic 
lung disease were associated with >3-fold higher mobility disability. Each standard deviation (SD) 
increase in depressive symptoms was associated with an 81% increase in the odds of mobility disability. 
Among women, knee pain was associated with almost two-fold, poor or very poor vision with more than 
three-fold, CVD history with a five-fold and PAD with more than ten-fold higher mobility disability. Each 
SD increase in waist circumference and depressive symptoms was associated with approximately 60% 
increased odds of mobility disability. Mean walking times were high in those men (435 seconds) and 
women (503 seconds) who completed the walk. Higher walking times were associated with higher waist 
circumference, knee pain and use of a walking aid in both men and women. 
Conclusion: In this cohort of community dwelling rural older Indians, the prevalence of mobility 
disability was high, particularly in women. Poor vision, knee pain and depression were the major risk 
factors. Potential targets for intervention include earlier diagnosis and better management of chronic 
disease and depression. Long-term follow-up of this population will provide an opportunity to 
understand the influence of mobility disability on incident morbidity and mortality.  
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5.2 Introduction 
Almost all nations in the world are now experiencing a growth in the number of older adults, though 
there is considerable variability. The most rapid increases in the older population are in the developing 
world [1]. This change towards an aging society is unprecedented and will result in increased disability 
and disease.  
India is the second most populous country in the world with 1.21 billion people in its 2011 census [5]. In 
2011, the 60+ population accounted for 8% of India population (93 million people). According to 
estimates, by the year 2050, the 60+ population will climb and account for 19% (323 million people) of 
the population [3]. As a result of this demographic shift, India is expected to face a higher burden of 
chronic disease and disability than any other country in the world over the next few decades.  
Mobility disability is a serious health problem encountered in the elderly, causing loss of independence 
and higher rates of morbidity and mortality. However, there is insufficient research from developing 
countries, including India, determining the prevalence of objectively measured mobility disability. Most 
of the research on disability from developing countries, including India has been recognized to be 
limited and of poor quality [122]. Nearly all estimates on aging, chronic disease and disability in India 
have been projected from small surveys conducted in specific sub-populations, causing concern that 
most of the data do not indicate the true measure of the problem [123]. Most current research has been 
done in urban older adults, even though more than two-third of the older adults in India live in rural 
areas [124-126]. Moreover, the estimates of disability have been assessed using self-reported diagnostic 
history or problems in activities of daily living, which may introduce biases to the estimates.  
The first aim of the present study was to estimate the prevalence of mobility disability in a rural Indian 
population aged >=60 years from the Mobility and Independent Living in Elders Study (MILES), using the 
400-meter usual paced walk as the measure of mobility disability. The ability or inability to walk 400 
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meters has been shown to predict future disability in self-care and mortality [13, 23, 45, 48-50]. It has 
been proposed that inability to walk 400 meters is an important threshold for classifying older adults as 
mobility disabled [127].  
The second aim of this study was to determine the risk factors for mobility disability in this population 
and its association with cardiovascular disease. We hypothesize that major mobility disability risk factors 
would be associated with prevalent mobility disability, independent of potential confounders. 
 
5.3 Methods 
5.3.1 Population 
The Mobility and Independent Living in Elders Study (MILES) enrolled 562 individuals aged 60 years or 
above from Medchal Mandal in Andhra Pradesh state, India. Equal number of men and women were 
randomly selected after conducting door-to-door recruitment in 10 villages from February 2012 to 
November 2012. Age was determined by the self-report from the Rural Effective Affordable Health Care 
(REACH) 2011 census. Eligibility was determined on participants’ ability to give informed consent 
(functional vision, hearing and cognitive function), physical ability to travel to the study clinic in a 
hospital vehicle, no plan to move from the area over the next 5 years and no end-stage diseases, such as 
terminal cancer, etc. Eligible participants were scheduled for a clinic visit where a written informed 
consent was obtained and comprehensive interview and clinical examination were conducted. A 
detailed description of the study has been published elsewhere (REF – MILES study design paper – 
Manuscript #1). 
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 5.3.2 Mobility disability 
Ability to walk 400 meters at usual pace was assessed on a 20-meter course (10 laps) in an open 
corridor.  Exclusion criteria were resting heart rate <40 or >135 beats per minute, systolic blood pressure 
>200 mmHg or a diastolic blood pressure >110 mmHg. Participants were asked about their ability and 
willingness to complete or attempt the walk and the test was conducted only for participants who felt 
comfortable to make an attempt to walk the course. Criteria for termination of the test were chest pain, 
tightness or pressure in the chest, shortness of breath, dizziness, lightheadedness or significant leg pain. 
Time taken to complete the course or partial laps, number of rest stops taken and reasons for failure or 
no attempt were recorded for all participants [85].  Mobility disability was defined as inability to attempt 
or complete the 400-meter walk. 
 
5.3.3 Measurements of risk factors and potential confounders 
Age, weight, waist circumference, poor vision, joint pain, joint stiffness, knee pain, hypertension, chronic 
lung disease, arthritis, depressive symptoms, self-reported cardiovascular disease and major ECG 
abnormality diabetes and peripheral artery disease were considered as risk factors for mobility 
disability. Sex, caste, religion, marital status, schooling or reading ability and smoking were examined as 
potential confounders. 
Information about caste, marital status and religion were collected from the participants. Number of 
years of schooling was determined by self-report and reading ability was assessed in individuals with 1-5 
years of schooling.  
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Seca 813 Digital Scale (Seca, Hanover, MD) was used to measure weight in kilograms (kg); and Gulick II 
tape measure was used to measure the waist circumference in centimeters.  
Smoking was classified as current, past, or never. Participants were asked about history of joint pain, 
stiffness or swelling lasting more than a month in the last 12 months, joint stiffness in the morning or 
after long periods of inactivity and knee pain lasting more than a month.  
Vision was rated and categorized by self-report as good, fair, poor or very poor. Arthritis was defined as 
a health professional’s diagnosis of osteoarthritis or rheumatoid arthritis. Depressive symptoms were 
assessed on the basis of 15-item Geriatric Depression Scale (GDS) [87, 128], which was translated to the 
local language (Telugu) and back translated to ensure accuracy. 
Participants were asked to fast overnight or for at least 10 hours before the clinic visit. Blood was 
obtained from fasting participants to measure blood sugar. Participants were asked to bring all 
prescription and non-prescription medications they had taken in the last 14 days. Dosage, frequency and 
duration were recorded and medications were categorized into classes. Diabetes was defined as self-
report of a health professional’s diagnosis, use of antidiabetic medication or a fasting blood glucose level 
greater than or equal to 126 mg/dL. 
Resting blood pressure was measured thrice in seated participants after an initial resting period of 5 
minutes using an Omron 705 automatic BP machine (Omron Healthcare, Inc., Lake Forest, IL).  Average 
of all three measurements was taken for analysis. Hypertension was defined as a self-report of a health 
professional’s diagnosis confirmed by the use of anti-hypertensive medication or by the measured blood 
pressure categorized according to the JNC 7 criteria [88].  
History of cardiovascular disease was defined as a self-report of a health professional’s diagnosis of 
myocardial infarction or stroke, or a history of angiography or coronary artery bypass graft.  
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Standard 12-lead resting electrocardiograms were obtained using GE MAC 600 (GE Healthcare) machine 
and were read by a physician and classified into major and minor ECG abnormalities [89]. Major ECG 
abnormality was defined to include major Q or QS abnormalities, left ventricular hypertension (LVH), 
isolated major ST-T wave abnormality, atrial fibrillation, first degree atrioventricular block, left bundle 
branch block (LBBB), right bindle branch block (RBBB) and intraventricular block of indeterminate type.  
Ankle brachial index (ABI) is the ratio of ankle to brachial systolic blood pressure and is <0.9 when there 
is obstruction to blood flow from atherosclerosis. ABI is a sensitive and specific measure of lower 
extremity peripheral artery disease. A handheld 8-megahertz Doppler probe with built-in speaker, and 
an OMRON 705 automatic BP machine was used to measure ankle and brachial blood pressure [90]. 
Peripheral artery disease was defined as an ABI of <0.9 or inability to find pulse in the lower extremities.  
 
5.3.4 Statistical analyses 
Descriptive analyses were conducted for all variables to assess proportions, means, standard deviations, 
normality, etc. Participant characteristics were compared for men and women using chi-square tests for 
categorical variables and t-tests for continuous variables.    
Prevalence of mobility disability was calculated in the overall sample and in men and women separately. 
Characteristics were compared for individuals with and without mobility disability. Bivariate associations 
between mobility disability and risk factors, including potential confounders were examined. Continuous 
variables were analyzed using standard deviation as a unit. Variables that were significant (p<0.25) in 
the bivariate analyses were included in the multivariate logistic regression model in stepwise logistic 
regression, along with variables that were determined a priori to be important based on previously 
published literature. The final multivariate model included significant (p<0.05) and a priori determined 
variables. All analyses were conducted for the total sample and men and women separately. 
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Linear regression was used to determine associations with 400-meter walk time in those who completed 
the walk. Bivariate and multivariate models were generated for men and women separately to identify 
predictors for 400-meter walk time. Use of walking aid was added as a predictor for walk time. Data 
were analyzed using Stata 12. 
 
5.4 Results 
5.4.1 Population characteristics 
Descriptive characteristics for the total sample are shown in Table 25. A total of 562 individuals (281 
men and women each) completed the baseline clinic visit in the study. The median age of men was 66 
years (range 60-90) and in women 65 years (range 60-92). More than 90% of the individuals were Hindu 
and a small number were Muslims and Christians. More than 90% of the men were currently married; 
however, less than half of the women were married. Men and women both had very low level of 
education with 91.5% of the women having had no schooling and only 26.5% of men having either more 
than or equal to 6 years of schooling or reading ability. Women were mostly non-smokers; however, 
nearly half the men were current smokers and one-third were past smokers. The median weight was low 
in both men (54.7 kg) and women (49.4 kg). Almost half of the men and women complained of knee 
pain lasting at least a month. Majority of the men and women had either fair or poor vision. Almost 40% 
of the women and 10% of the men had depressive symptoms suggestive of mild or severe depression. 
About a quarter of women and 14% of the men had diagnosed arthritis. Ten percent of men and women 
had a history of chronic lung disease. Even though not significantly different, diabetes was more 
prevalent in women (23.3%) than men (17.9%). About half of both men and women were hypertensive.  
 
92 
5.4.2 Mobility disability 
Table 26 shows the prevalence of mobility disability in men and women. The prevalence of mobility 
disability was much higher in women (43.8%) compared to men (27.9%). Of the individuals who did not 
complete the 400-meter walk, 6.8% of the men and 5.7% of the women did not attempt the walk.  
Tables 27, 28 and 29 compare the characteristics of the total sample, men and women with respect to 
mobility disability. Men, who were unable to complete the walk were more likely to have a history of 
knee pain, fair or poor vision, chronic lung disease and greater number of depressive symptoms. Among 
women with mobility disability, waist circumference was higher and they were more likely to have 
history of knee pain, poor vision, arthritis, greater number of depressive symptoms, history of CVD and 
peripheral artery disease compared to the group without mobility disability.     
5.4.3 Bivariate and multivariate analyses 
Tables 30, 31 and 32 show the bivariate logistic regression analyses between mobility disability and risk 
factors in the total sample, men and women separately. Among men, knee pain, fair vision, chronic lung 
disease and greater number of depressive symptoms were associated with mobility disability in bivariate 
analyses. Ability to read or six years or more of schooling was associated with lower odds of mobility 
disability. In women, higher waist circumference, joint pain, joint stiffness, knee pain, fair or poor vision, 
hypertension, arthritis, greater number of depressive symptoms, CVD history and PAD were associated 
with mobility disability. Age was not significantly associated with mobility disability in ether men or 
women.  
Multivariate logistic regression analyses were conducted to ascertain the strength of relationship 
between mobility disability and risk factors after adjustments for potential confounders. The final 
multivariate models for the total sample, men and women are shown in tables 33, 34 and 35. Age was 
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not associated with mobility disability in either men or women. In men, history of knee pain lasting at 
least a month, fair vision and chronic lung disease were associated independently with more than three-
fold higher mobility disability. Each standard deviation increase in depressive symptoms was associated 
with an 81% increase in the odds of mobility disability. Among women, history of knee pain was 
associated with almost two-fold, poor or very poor vision with more than three-fold, CVD history with a 
five-fold and PAD with more than ten-fold higher mobility disability. Each standard deviation increase in 
waist circumference and depressive symptoms was associated with approximately 60% increased odds 
of mobility disability.   
5.4.4 Time to complete 400-meter walk in those who completed the walk 
In the analyses for time to walk 400 meters, the median walking time was significantly higher in women 
(503 seconds) compared to men (435 seconds) (Table 36). Among the 360 participants who completed 
the walk, walking times were available for 353 individuals. Nine men out of 197 and 8 women out of 156 
used a walking aid (Table 37).  
Tables 38, 39 and 40 show the results of bivariate linear regression analyses between walking time and 
other variables in the total sample, men and women respectively. In men, age, joint pain, knee pain, 
arthritis, greater number of depressive symptoms, CVD history and use of a walking aid were associated 
with greater walking time. Among women, bivariate linear regression analyses showed associations of 
age, joint pain, joint stiffness, knee pain, chronic lung disease, greater number of depressive symptoms, 
and use of a walking aid with increased walking time. Greater height was associated with lower walking 
times. 
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Tables 41, 42 and 43 show multivariate linear regression analyses for walking time for the total sample, 
men and women. Among men, each year increase in age and each centimeter increase in waist 
circumference were associated with a slight increase in walking times. History of knee pain was 
associated with a 26 seconds increase, and use of walking aid was associated with a more than 100 
seconds increase in walking time. Among women, each kilogram increase in weight was associated with 
slightly lower walking time and each centimeter increase in waist circumference was with slightly higher 
walking times. History of knee pain was associated with a 38 seconds increase, and use of walking aid 
was associated with a more than 120 seconds increase in walking time. 
    
5.5 Discussion 
In this cohort of community dwelling rural Indians aged 60 years and above, the prevalence of mobility 
disability, identified by inability to complete or attempt a 400-meter walk was high. Almost 45% of the 
women and more than a quarter of the men had mobility disability. In men, mobility disability was 
associated with a history of knee pain, chronic lung disease, poor vision and greater number of 
depressive symptoms. In women, mobility disability was associated with higher waist circumference, 
history of knee pain, poor vision greater number of depressive symptoms, history of CVD and peripheral 
artery disease.  
It has been shown in previous literature that even though progress has been made by India in extending 
the life span of its residents, this success has not been carried over to better health care provision or 
management of disability for older adults [129, 130]. As there is no reliable monitoring and reporting for 
health and disability related condition, most of the data and generalizations about prevalence are from 
small samples [131]. Most studies have depended upon data released by the National Sample Survey 
Organization (NSSO) or smaller studies with limited generalizability or survey style data collection. As a 
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result, the estimates of mobility disability vary widely between studies. According to NSSO, 
approximately 5% of elderly in rural and urban India were immobile or unable to move without help and 
older women had more physical health issues [132]. In another study, 45% of the older participants 
complained of problems in walking and 26% of rural women needed help with at least one activity of 
daily living [130]. A study in rural older Indians aged 60 and above estimated the prevalence of self-
reported agility disability (defined as functional limitation in locomotion, walking, climbing stairs, body 
movement and dexterity) to be 30% in men and 35% in women [133].  
In our analyses, age was not associated with mobility disability in MILES participants. This could be 
because of the inaccuracy of the reported age, as majority of the population did not have birth 
certificates and had difficulty reporting their correct age.  
Most studies, including ours have shown higher prevalence of disability in older women compared to 
men [23, 56, 134]. Several explanations have been proposed to understand these differences. The 
prevalence of mobility disability was more than 50% higher in women compared to men and such 
difference might represent a survival effect for women. Other theories to explain this difference include 
greater perception of functional impairment in women compared with men [135] and higher rates of 
comorbidity or chronic health conditions in women, including depression, dementia and osteoarthritis 
[136]. This was also true in MILES where we saw higher prevalence of chronic conditions in women and 
their relationship with mobility disability. Another recent study by Tseng et al. found poorer physical 
function in women related to their higher fat mass compared to men, and by other body composition 
differences [137]. They found that higher proportion of body fat in women may put them at significant 
biomechanical disadvantage for greater disability in old age [137]. Furthermore, as results from MILES 
and other previous studies have shown, older women in rural India are likely to be illiterate or poorly 
educated and unlikely to hold a remunerative job. As a result of this, they are dependent on others for 
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economic needs [129]. This might lead to women having poor health awareness and access to health 
care, increasing disease and disability, particularly in the older age groups. Moreover, policymakers and 
health care advisors have ignored this vulnerable group, and very little funding is allotted to the health 
needs of the older women in India [129].  
Greater number of depressive symptoms was associated with mobility disability in both men and 
women. Several studies of older adults across rural and urban parts of India have shown geriatric 
depression to be highly prevalent. The estimates have varied between 6% and 43%, with higher 
proportion of women being affected [130, 138, 139][140]. In a study of inpatients in geriatric ward, Shah 
et al. detected depressive symptoms in 40% of the patients [129]. Depression was shown to be 
associated with mobility disability in several cross-sectional studies and as predictor of future mobility 
disability in older adults [141-143]. Even though almost half of the participants reported depressive 
symptoms in our study, none of them were on antidepressant treatment. Undiagnosed and untreated 
depression may lead to increased disability in this already highly disabled population.  
Problems with vision was another factor that was independently associated with mobility disability in 
men as well as women. More than 50% of the participants reported having fair or poor vision in MILES. 
Similar results have been observed in previous studies in older Indians [129, 130]. Poor vision was 
associated with mobility disability and poor physical function in several epidemiological studies [144, 
145].  
Several other chronic conditions and diseases, including history of knee pain, lung disease, CVD and PAD 
were also associated with mobility disability. These conditions were associated with prevalent and 
incident mobility disability and poor physical performance in other cohorts of older adults [38, 60, 67-
69, 78, 146]. There was high prevalence of these chronic conditions in MILES participants. Chronic 
diseases, including cardiovascular disease have been a major health problem in developed countries for 
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a long time, but their presence in developing countries has been escalating only in the last few years. 
There are numerous factors contributing to this rise, including demographic shifts with altered age 
profiles, lifestyle and diet changes related to rapid urbanization, among several others [147, 148]. With 
advances in health care in developing countries, the population suffering from chronic disease is living to 
be older than ever before and this has led to an increase in disability due to these conditions in the older 
age groups.      
In this study, more than 6% participants did not attempt the walk and almost 38% of the women and 
21% men started the walk, but could not complete it. Of those who completed the walk, the mean 
walking time was 435 seconds for men and 503 seconds for women. By comparison, in a study of well-
functioning older American men and women aged 70-79 years, mean walking time was 320 seconds in a 
400-meter walk protocol demanding faster walk [54]. Another study of Italian older adults aged 65-91 
year showed the mean 400-meter walking time to be 331 seconds [48]. Data from a physical activity 
clinical trial in American elderly participants aged 70-85 years showed similar walking time as MILES 
participants [149].  
Greater walking times were associated with higher waist circumference, knee pain and use of a walking 
aid in both men and women. Greater number of depressive symptoms was associated with increased 
walking times for the total sample, but lost significance when analyzing men and women separately. 
Sample sizes are much smaller for this subset of participants who completed the walk, particularly when 
analyzing men and women separately.  
There are several strengths to this study. To our knowledge, this is the first study in Indian older adults 
to identify mobility disability by using the participants’ ability to complete a 400-meter walk. As self-
report can give biased estimates, the objective measurement of mobility presents a more accurate 
prevalence. Moreover, most self-report questionnaires identify an advanced stage of disability, and do 
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not discriminate at the level of high physical function. They have low sensitivity, provide very little 
information about the physical function of higher functioning individuals (ceiling effect) and identify 
persons whose ability to perform basic functions has already been impaired. 
There were a few limitation of this study. The data analyzed in this effort are cross-sectional and causal 
relationships cannot be inferred, in particular for the relationship between depression and mobility 
disability. Also, because the study enrollment demanded that participants be physically able to at least 
walk a few steps and travel in a hospital vehicle to reach the clinic, severely disabled individuals could 
not be included in the study. Some information on risk factors was based on a health professional’s 
diagnosis of that disease and may have been underestimated because of undiagnosed disease, poor 
health awareness and limited health care access in this population. Despite these limitations, MILES 
provides much needed estimates for prevalence and risk factors of mobility disability and offers novel 
opportunities for further research in this critical health issues in older adults.  
Understanding the burden of mobility disability is crucial in this rapidly aging population. Mobility 
disability is shown to be risk factor for several geriatric conditions, including falls, fractures, cognitive 
decline, dementia and functional decline. Decreased mobility due to impaired mobility leads to further 
increase in health problems in older adults, including loss of muscle mass and strength, and 
deterioration of other chronic conditions, increasing the risk of institutionalization and death [16, 43, 47, 
58, 61, 62]. 
The high prevalence of depressive symptoms observed among older adults indicates an urgent need, 
both for greater awareness of depression among community members and to ensure availability and 
accessibility of appropriate health care services to manage depression. At the same time, it is important 
to increase community support and create networks for better geriatric care. These results suggest that 
prevention or reduction of depressed mood could play a role in reducing functional decline in older 
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persons. Improvement in vision is a very important modifiable risk factor for mobility disability and more 
effort is needed to provide access to corrective surgery and prosthetic aids to neglected and vulnerable 
populations. Timely detection of subclinical disease may allow for early treatment opportunities leading 
to improved survival and lowering disability in older population. Earlier diagnosis and better 
management of chronic conditions may delay the development of mobility disability and related 
morbidity. Risk factor modification may not only prevent disability, but can also have an impact on 
improving quality of life in older adults.  
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5.6 Mobility disability tables 
Table 25: Descriptive characteristics of all MILES participants at baseline 
 Characteristic Men (N=281) Women (N=281) p-value 
Age (years), median (range) 66 (60-90) 65 (60-92) 0.163 
Marital status     <0.001 
Currently married, N (%) 253 (90.4) 109 (38.8) 
Widowed, N (%) 26 (9.3) 169 (60.1) 
Divorced/abandoned, N (%) 1 (0.3) 3 (1.1) 
Religion   0.514 
              Hindu, N (%) 258 (92.1)  253 (90.0) 
              Muslim, N (%) 11 (3.9) 17 (6.1) 
             Christian, N (%) 11 (3.9) 11 (3.9) 
Caste    0.598 
              Scheduled caste, N (%) 37 (13.2)  48 (17.1) 
              Scheduled tribe, N (%) 17 (6.1) 16 (5.7) 
              Backward caste, N (%) 157 (56.1) 146 (52.0) 
              Other, N (%) 69 (24.6) 71 (25.3) 
Schooling and reading ability, N (%)   <0.001 
No schooling, N (%) 148 (53.1) 257 (91.5) 
<6 years of schooling and not able to 
read, N (%) 
57 (20.4) 11 (3.9) 
>=6 years of schooling or able to 
read 
74 (26.5) 13 (4.6) 
Currently not working, N (%) 157 (56.1) 217 (77.2) <0.001 
Health status (self-reported)     0.163 
Good, N (%) 134 (47.9) 118 (42.0) 
Fair, N (%) 144 (51.4) 120 (42.7) 
Poor, N (%) 2 (0.7) 43 (15.3) 
Weight (kg), median (range) 54.7 (28.9-92.2) 49.4 (28.3-108.7) <0.001 
Height (cm), median (range) 161.2 (141.3-
177.7) 
147.4 (128.0-
162.9) 
<0.001 
BMI (kg/m2), median (range) 21.2 (13.6-33.1) 22.5 (14.3-43.7) <0.001 
Waist circumference (cm), median (range) 83.0 (52.9-112.3) 78.8 (54.7-132.6) 0.004 
Smoking   <0.001 
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                Current, N (%) 121 (43.1) 1 (0.4) 
                Past, N (%) 91 (32.4) 6 (2.1) 
                Never, N (%) 69 (24.6) 274 (97.5) 
Alcohol, N (%) 199 (71.1) 161 (57.3) 0.001 
Hemoglobin (g/dL), median (IQR) 13.9 (12.4-15.1) 12.4 (11.5-13.1) <0.001 
Joint pain, stiffness, swelling lasting >1 
month in last 12 months, N (%) 
93 (33.2) 61 (21.7) 0.002 
Joint stiffness in morning/ after inactivity, N 
(%) 
92 (32.9) 161 (57.3) <0.001 
Knee pain lasting >1 month, N (%) 136 (48.6) 133 (47.3) 0.769 
Not physically active (not walking 10 
minutes continuously every day), N (%) 
74 (26.4) 123 (43.8) <0.001 
Difficulty in walking short distances (self-
reported), N (%) 
88 (31.4) 167 (59.4) <0.001 
Difficulty in walking long distances (self-
reported), N (%) 
203 (72.5) 222 (79.0) 0.072 
Vision (self-reported)   <0.001 
Good, N (%) 114 (40.7) 98 (34.9) 
Fair, N (%) 163 (58.2) 97 (34.5) 
Poor/very poor, N (%) 3 (1.1) 86 (30.6) 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
137 (48.8) 143 (50.9) 0.613 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
50 (17.9) 65 (23.30) 0.112 
Depression categories (15-item GDS)   <0.001 
No depression (<=5 depressive 
answers), N (%) 
247 (89.2) 170 (60.7) 
Mild depression (6-10 depressive 
items), N (%) 
21 (7.6) 66 (23.6) 
Severe depression (>10 depressive 
answers), N (%) 
9 (3.3) 44 (15.7) 
Arthritis (self-reported), N (%) 40 (14.3) 67 (23.8) 0.004 
Chronic lung disease (self-reported), N (%) 27 (9.6) 29 (10.3) 0.789 
CVD history (self-reported), N (%)  28 (10.0) 16 (5.7) 0.058 
ECG abnormality, N (%) 44 (15.7) 44 (15.7) 1.000 
Peripheral artery disease, N (%) 17 (6.1) 20 (7.1) 0.626 
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Table 26: Prevalence of mobility disability (non-completion of 400 meter walk) in men and women 
 Men (N=280) Women (N=280) p-value 
400 meter walk (non-completers), N (%) 78 (27.9) 123 (43.8) <0.001 
400 meter walk status   <0.001 
Not attempted, N (%) 19 (6.8) 17 (5.7) 
Attempted, but not completed, N 
(%)  
59 (21.1) 106 (37.9) 
Completed, N (%) 202 (72.1) 158 (56.4) 
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Table 27: Characteristics of all MILES participants by mobility disability (400 meter walk not 
completed) 
 Characteristic With mobility 
disability (N=201) 
Without mobility 
disability 
(N=360) 
p-value 
Age (years), mean (SD) 68.2 (6.2) 67.2 (6.6) 0.087 
Male sex, N (%) 78 (38.8) 202 (56.1) <0.001 
Not currently married, N (%)   90 (44.8) 109 (30.3) 0.001 
Schooling and reading ability, N (%)   <0.001 
No schooling, N (%) 159 (79.5) 246 (68.3) 
<6 years of schooling and not able to 
read, N (%) 
26 (13.0) 42 (11.7) 
>=6 years of schooling or able to 
read 
15 (7.5) 72 (20.0) 
BMI (kg/m2), mean (SD) 22.7 (5.1) 22.0 (4.2) 0.08 
Waist circumference (cm), mean (SD) 81.4 (14.1) 80.3 (12.6) 0.318 
Smoking   0.078 
                Never, N (%) 135 (67.2) 207 (57.5) 
                Past, N (%) 30 (14.9) 67 (18.6) 
                Current, N (%) 36 (17.9) 86 (23.9) 
Joint pain, stiffness, swelling lasting >1 month 
in last 12 months, N (%) 
63 (31.3) 91 (25.3) 0.123 
Joint stiffness in morning/ after inactivity, N 
(%) 
109 (54.2) 144 (40.0) 0.001 
Knee pain lasting >1 month, N (%) 127 (63.2) 142 (39.4) <0.001 
Difficulty in walking short distances (self-
reported), N (%) 
152 (75.6) 103 (28.6) <0.001 
Difficulty in walking long distances (self-
reported), N (%) 
192 (95.5) 233 (64.7) <0.001 
Vision (self-reported)   <0.001 
Good, N (%) 44 (21.9) 168 (46.7) 
Fair, N (%) 105 (52.2) 155 (43.1) 
Poor/very poor, N (%) 52 (25.9) 37 (10.3) 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
111 (55.2) 170 (47.2) 0.069 
Chronic lung disease (self-reported), N (%) 28 (13.9) 28 (7.8) 0.020 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
50 (25.1) 65 (18.1) 0.048 
Arthritis (self-reported), N (%) 53 (26.4) 54 (15.0) 0.001 
Depression categories (15-item GDS)   <0.001 
No depression (<=5 depressive 118 (59.6) 299 (83.3) 
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answers), N (%) 
Mild depression (6-10 depressive 
answers), N (%) 
44 (22.2) 43 (12.0) 
Severe depression (>10 depressive 
answers), N (%) 
36 (18.2) 17 (4.7) 
CVD history (self-reported), N (%)  23 (11.4) 21 (5.8) 0.018 
ECG abnormality, N (%) 41 (20.4) 46 (12.8) 0.017 
Peripheral artery disease, N (%) 24 (12.0) 13 (3.6) <0.001 
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Table 28: Characteristics of men by mobility disability (400 meter walk not completed) 
 Characteristic With mobility 
disability (N=78) 
Without mobility 
disability 
(N=202) 
p-value 
Age (years), mean (SD) 68.6 (6.3) 67.7 (6.7) 0.332 
Not currently married, N (%)  8 (10.3) 19 (9.4) 0.829 
Schooling and reading ability, N (%)   0.011 
No schooling, N (%) 45 (58.4) 103 (51.0) 
<6 years of schooling and not able to 
read, N (%) 
21 (27.3) 36 (17.8) 
>=6 years of schooling or able to 
read 
11 (14.3) 63 (31.2) 
BMI (kg/m2), mean (SD) 21.2 (3.8) 21.5 (4.0) 0.512 
Waist circumference (cm), mean (SD) 82.2 (11.7) 82.3 (12.5) 0.918 
Smoking   0.472 
                Never, N (%) 15 (19.2) 53 (26.2) 
                Past, N (%) 27 (34.6) 64 (31.7) 
                Current, N (%) 36 (46.2) 85 (42.1) 
Joint pain, stiffness, swelling lasting >1 month 
in last 12 months, N (%) 
28 (35.9) 65 (32.2) 0.554 
Joint stiffness in morning/ after inactivity, N 
(%) 
30 (38.5) 62 (30.7) 0.215 
Knee pain lasting >1 month, N (%) 54 (69.2) 82 (40.6) <0.001 
Difficulty in walking short distances (self-
reported), N (%) 
52 (66.7) 36 (17.8) <0.001 
Difficulty in walking long distances (self-
reported), N (%) 
76 (97.4) 127 (62.9) <0.001 
Vision (self-reported)   <0.001 
Good, N (%) 14 (18.0) 100 (49.5) 
Fair, N (%) 61 (78.2) 102 (50.5) 
Poor/very poor, N (%) 3 (3.9) 0 (0.0) 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
42 (53.9) 101 (50.0) 0.564 
Chronic lung disease (self-reported), N (%) 14 (18.0) 13 (6.4) 0.003 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
16 (20.5) 34 (16.8) 0.471 
Arthritis (self-reported), N (%) 13 (16.7) 27 (13.4) 0.479 
Depression categories (15-item GDS)   0.001 
No depression (<=5 depressive 
answers), N (%) 
60 (80.0) 187 (92.6) 
Mild depression (6-10 depressive 
items), N (%) 
8 (10.7) 13 (6.4) 
106 
Severe depression (>10 depressive 
answers), N (%) 
7 (9.3) 2 (1.0) 
CVD history (self-reported), N (%)  11 (14.1) 17 (8.4) 0.155 
ECG abnormality, N (%) 17 (21.8) 26 (12.9) 0.063 
Peripheral artery disease, N (%) 8 (10.4) 9 (4.5) 0.064 
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Table 29: Characteristics of women by mobility disability (400 meter walk not completed) 
 Characteristic With mobility 
disability (N=123) 
Without mobility 
disability 
(N=158) 
p-value 
Age (years), mean (SD) 68.0 (6.1) 66.6 (6.3) 0.071 
Not currently married, N (%) 82 (66.7) 90 (57.0) 0.098 
BMI (kg/m2), mean (SD) 23.7 (5.5) 22.7 (4.4) 0.083 
Waist circumference (cm), mean (SD) 81.0 (15.4) 77.6 (12.3) 0.045 
Joint pain, stiffness, swelling lasting >1 
month in last 12 months, N (%) 
35 (28.5) 26 (16.5) 0.015 
Joint stiffness in morning/ after inactivity, N 
(%) 
79 (64.2) 82 (51.9) 0.038 
Knee pain lasting >1 month, N (%) 73 (59.4) 60 (38.0) <0.001 
Difficulty in walking short distances (self-
reported), N (%) 
100 (81.3) 67 (42.4) <0.001 
Difficulty in walking long distances (self-
reported), N (%) 
116 (94.3) 106 (67.1) <0.001 
Vision (self-reported) 0.001 
Good, N (%) 30 (24.4) 68 (43.0) 
Fair, N (%) 44 (35.8) 53 (33.5) 
Poor/very poor, N (%) 49 (39.8) 37 (23.4) 
Hypertension (BP>=140/90 and/or self-
reported AND medication use), N (%) 
69 (56.1) 69 (43.7) 0.039 
Chronic lung disease (self-reported), N (%) 14 (11.4) 15 (9.5) 0.606 
Diabetes, N (%) (self-reported and/or 
FBS>=126 and/or medication use) 
34 (28.1) 31 (19.6) 0.097 
Arthritis (self-reported), N (%) 40 (32.5) 27 (17.1) 0.003 
Depression categories (15-item GDS) 0.001 
No depression (<=5 depressive 
answers), N (%) 
58 (47.2) 112 (71.3) 
Mild depression (6-10 depressive 
items), N (%) 
36 (29.3) 30 (19.1) 
Severe depression (>10 depressive 
answers), N (%) 
29 (23.6) 15 (9.6) 
CVD history (self-reported), N (%) 12 (9.8) 4 (2.5) 0.010 
ECG abnormality, N (%) 24 (19.5) 20 (12.7) 0.117 
Peripheral artery disease, N (%) 16 (13.0) 4 (2.5) 0.001 
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Table 30: Bivariate logistic regression analyses of mobility disability (400 meter walk not completed) 
for the total sample 
Odds Ratio 95% confidence 
interval 
p-value 
Age 1.02 1.00–1.05 0.088 
Male sex 0.50 0.35–0.71 <0.001 
Caste 
Other 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 0.90 0.59–1.37 0.617 
Scheduled caste/Scheduled tribe 1.16 0.70–1.91 0.575 
Not currently married 1.87 1.31–2.67 0.001 
Schooling and reading ability 
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 0.96 0.56–1.62 0.873 
>=6 years of school or able to read 0.32 0.18–0.58 <0.001 
BMI (per SD) 1.16 0.98–1.38 0.081 
Waist circumference (per SD) 1.09 0.92–1.30 0.318 
Smoking 
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 0.69 0.42–1.11 0.126 
Current smoking 0.64 0.41–1.00 0.051 
Chewing tobacco 1.45 0.99–2.11 0.054 
Joint pain, stiffness, swelling 1.35 0.92–1.98 0.123 
Joint stiffness in morning/ after inactivity 1.78 1.25–2.52 0.001 
Knee pain lasting >1 month 2.63 1.85–3.76 <0.001 
Vision (self-reported) 
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 2.59 1.71–3.91 <0.001 
Poor/very poor 5.37 3.14–9.18 <0.001 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
1.38 0.97–1.95 0.070 
Chronic lung disease 1.92 1.10–3.34 0.021 
Diabetes 1.52 1.00–2.31 0.049 
Arthritis 2.03 1.32–3.11 0.001 
Depression score (per SD) 1.94 1.61–2.33 <0.001 
CVD history (self-reported) 2.09 1.12–3.87 0.020 
ECG abnormality 1.75 1.10–2.78 0.018 
Peripheral artery disease 3.64 1.81–7.32 <0.001 
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Table 31: Bivariate logistic regression analyses of mobility disability (400 meter walk not completed) 
for men 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.02 0.98–1.06 0.331 
Caste    
Other 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 0.73 0.39–1.37 0.327 
Scheduled caste/Scheduled tribe 1.24 0.58–2.65 0.577 
Not currently married 1.10 0.46–2.63 0.829 
Schooling and reading ability    
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 1.34 0.70–2.54 0.378 
>=6 years of school or able to read 0.40 0.19–0.83 0.014 
BMI (per SD) 0.90 0.67–1.22 0.510 
Waist circumference (per SD) 0.99 0.74–1.30 0.918 
Smoking    
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.49 0.72–3.09 0.283 
Current smoking 1.50 0.75–2.99 0.254 
Chewing tobacco 0.33 0.07–1.47 0.145 
Joint pain, stiffness, swelling 1.18 0.68–2.04 0.554 
Joint stiffness in morning/ after inactivity 1.41 0.82–2.43 0.216 
Knee pain lasting >1 month 3.29 1.89–5.75 <0.001 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 4.27 2.25–8.13 <0.001 
Poor/very poor (omitted)    
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
1.17 0.69–1.97 0.564 
Chronic lung disease 2.10 1.13–3.91 0.019 
Diabetes 1.28 0.66–2.47 0.472 
Arthritis 1.30 0.63–2.66 0.480 
Depression score (per SD) 1.98 1.40–2.81 <0.001 
CVD history (self-reported)  1.79 0.80–4.01 0.159 
ECG abnormality 1.89 0.96–3.71 0.066 
Peripheral artery disease 2.49 0.92–6.70 0.072 
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Table 32: Bivariate logistic regression analyses of mobility disability (400 meter walk not completed) 
for women 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.04 1.00–1.08 0.073 
Caste    
Other 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Backward caste 1.10 0.62–1.94 0.752 
Scheduled caste/Scheduled tribe 1.06 0.54–2.10 0.861 
Not currently married 1.51 0.93–2.47 0.098 
Schooling and reading ability    
No schooling 1.00 (ref) 1.00 (ref) 1.00 (ref) 
<6 years of school & inability to read 1.05 0.31–3.51 0.943 
>=6 years of school or able to read 0.56 0.17–1.86 0.341 
BMI (per SD) 1.21 0.97–1.51 0.084 
Waist circumference (per SD) 1.26 1.01–1.58 0.046 
Chewing tobacco 1.16 0.72–1.86 0.543 
Joint pain, stiffness, swelling 2.02 1.14–3.59 0.017 
Joint stiffness in morning/ after inactivity 1.66 1.03–2.70 0.039 
Knee pain lasting >1 month 2.38 1.47–3.86 <0.001 
Vision (self-reported)    
Good    
Fair 1.88 1.05–3.38 0.035 
Poor/very poor 3.00 1.64–5.50 <0.001 
Chronic lung disease 1.22 0.57–2.64 0.606 
Hypertension (BP>=140/90 and/or self-
reported AND medication use) 
1.65 1.02–2.65 0.039 
Diabetes 1.60 0.92–2.80 0.098 
Arthritis 2.34 1.34–4.09 0.003 
Depression score (per SD) 1.78 1.39–2.28 <0.001 
CVD history (self-reported)  4.16 1.31–13.25 0.016 
ECG abnormality 1.67 0.88–3.19 0.119 
Peripheral artery disease 5.76 1.87–17.70 0.002 
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Table 33: Multivariate logistic regression analyses of mobility disability (400 meter walk not 
completed) for the total sample 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.02 0.99–1.05 0.177 
Male sex 0.71 0.43–1.15 0.160 
Waist circumference (per SD) 1.29 1.05–1.59 0.016 
Knee pain lasting >1 month 2.39 1.58–3.59 <0.001 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 2.45 1.55–3.88 <0.001 
Poor/very poor 4.23 2.29–7.85 <0.001 
Depression score (per SD) 1.60 1.28–2.00 <0.001 
CVD history (self-reported)  2.06 1.01–4.18 0.047 
Peripheral artery disease 4.59 2.05–10.26 <0.001 
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Table 34: Multivariate logistic regression analyses of mobility disability (400 meter walk not 
completed) for men 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.00 0.95–1.05 0.988 
Waist circumference (per SD) 1.22 0.85–1.73 0.275 
Smoking    
Never smoked 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Past smoking 1.22 0.52–2.87 0.651 
Current smoking 1.50 0.65–3.45 0.346 
Knee pain lasting >1 month 3.28 1.68–6.40 0.001 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 3.87 1.87–7.98 <0.001 
Poor/very poor (Omitted)    
Chronic lung disease 3.01 1.09–8.33 0.034 
Diabetes 1.17 0.50–2.72 0.717 
Arthritis 0.74 0.29–1.87 0.525 
Depression score (per SD) 1.81 1.18–2.77 0.006 
Peripheral artery disease 2.22 0.66–7.45 0.199 
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Table 35: Multivariate logistic regression analyses of mobility disability (400 meter walk not 
completed) for women 
 Odds Ratio 95% confidence 
interval 
p-value 
Age 1.04 1.00–1.09 0.066 
Waist circumference (per SD) 1.58 1.16–2.16 0.004 
Knee pain lasting >1 month 1.94 1.07–3.52 0.029 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 1.79 0.91–3.52 0.093 
Poor/very poor 3.41 1.67–6.94 0.001 
Chronic lung disease 0.49 0.19–1.26 0.139 
Diabetes 1.20 0.61–2.38 0.596 
Arthritis 1.75 0.90–3.39 0.100 
Depression score (per SD) 1.63 1.20–2.21 0.002 
CVD history (self-reported) 5.07 1.36–18.95 0.016 
Peripheral artery disease 10.47 2.72–40.26 0.001 
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Table 36: Time taken (seconds) to complete 400 meters walk for completers 
 Men (N=197) Women (N=156) p-value 
400 meter walk time (seconds), mean 
(IQR) 
435 (385–470) 503 (448–542) <0.001 
 
 
Table 37: Use of walking aid for 400 meter walk for completers and non-completers 
 Men Women 
Walking aid used in all 400 meter walk attempters (Total 
N=525), N (%) 
30 (11.5) 31 (11.7) 
Walking aid used in completers (Total N=360), N (%) 9 (4.5) 8 (5.0) 
Walking aid used in non-completers (Total N=165), N (%) 21 (35.6) 23 (21.5) 
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Table 38: Bivariate linear regression analyses of time to complete 400 meter walk (in seconds) for the 
total sample 
Variables Beta 
coefficient 
95% confidence 
interval 
p-value 
Age 1.90 0.54, 3.26 0.006 
Male sex -68.52 -85.14, -51.89 <0.001 
Not currently married 47.21 28.22, 66.20 <0.001 
Weight -0.90 -1.66, -0.14 0.021 
Height -3.61 -4.59, -2.63 <0.001 
Waist circumference -0.18 -0.89, 0.53 0.623 
Joint pain, stiffness, swelling 21.83 1.39, 42.27 0.036 
Joint stiffness in morning/ after inactivity 37.52 19.57, 55.46 <0.001 
Knee pain lasting >1 month 34.80 16.72, 52.87 <0.001 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 13.72 -5.07, 32.50 0.152 
Poor/very poor 47.48 16.79, 78.17 0.003 
Chronic lung disease 55.52 22.74, 88.30 0.001 
Diabetes -1.23 -24.73, 22.27 0.918 
Arthritis 30.83 6.05, 55.62 0.015 
Depressive symptoms 9.59 6.98–12.20 <0.001 
CVD history (self-reported)  3.96 -34.08, 41.99 0.838 
Peripheral artery disease -19.64 -67.37, 28.09 0.419 
Use of walking aid 122.91 82.88, 162.95 <0.001 
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Table 39: Bivariate linear regression analyses of time to complete 400 meter walk (in seconds) for men 
Variables Beta 
coefficient 
95% confidence 
interval 
p-value 
Age 2.40 0.85, 3.94 0.003 
Not currently married 5.20 -31.70, 42.11 0.781 
Weight 0.31 -0.60, 1.22 0.498 
Height -0.37 -2.31, 1.57 0.705 
Waist circumference 0.59 -0.25, 1.44 0.167 
Joint pain, stiffness, swelling 32.25 10.09, 54.41 0.005 
Joint stiffness in morning/ after inactivity 18.41 -4.45, 41.27 0.114 
Knee pain lasting >1 month 29.08 7.82, 50.35 0.008 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 15.14 -6.02, 36.31 0.160 
Poor/very poor (omitted)    
Chronic lung disease 36.79 -5.74, 79.32 0.090 
Diabetes -20.07 -48.77, 8.63 0.169 
Arthritis 42.91 12.58, 73.23 0.006 
Depressive symptoms 7.08 2.50, 11.67 0.003 
CVD history (self-reported)  38.75 1.26, 76.23 0.043 
Peripheral artery disease -8.78 -59.71, 42.14 0.734 
Use of walking aid 109.43 60.76, 158.09 <0.001 
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Table 40: Bivariate linear regression analyses of time to complete 400 meter walk (in seconds) for 
women 
Variables Beta coefficient 95% confidence 
interval 
p-value 
Age 2.33 0.27–4.39 0.027 
Not currently married 15.56 -10.88, 41.99 0.247 
Weight -0.91 -2.10, 0.28 0.132 
Height -2.62 -4.85, -0.38 0.022 
Waist circumference -0.07 -1.13, 1.00 0.898 
Joint pain, stiffness, swelling 48.18 13.70, 82.67 0.006 
Joint stiffness in morning/ after inactivity 30.52 4.63, 56.41 0.021 
Knee pain lasting >1 month 47.96 21.81, 74.11 <0.001 
Vision (self-reported)    
Good 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Fair 22.66 -7.51, 52.84 0.140 
Poor/very poor 7.97 -25.79, 52.84 0.642 
Chronic lung disease 59.34 15.69, 102.99 0.008 
Diabetes 10.38 -22.57, 43.33 0.535 
Arthritis 8.77 -26.00, 43.54 0.619 
Depressive symptoms 5.59 1.98, 9.20 0.003 
CVD history (self-reported)  -41.55 -124.58, 41.48 0.324 
Peripheral artery disease -13.07 -96.33, 70.20 0.757 
Use of walking aid 134.02 78.27, 189.76 <0.001 
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Table 41: Multivariate linear regression analyses of time to complete 400 meter walk (in seconds) for 
the total sample 
Variables Beta 
coefficient 
95% confidence 
interval 
p-value 
Age 1.39 0.22, 2.55 0.020 
Male sex -58.41 -75.29, -41.54 <0.001 
Weight -2.85 -4.38, -1.32 <0.001 
Waist circumference 3.13 1.74, 4.53 <0.001 
Knee pain lasting >1 month 32.98 17.71, 48.24 <0.001 
Depressive symptoms 3.61 1.01, 6.22 0.007 
Use of walking aid 111.52 76.06, 146.97 <0.001 
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Table 42: Multivariate linear regression analyses of time to complete 400 meter walk (in seconds) for 
men 
Variables Beta 
coefficient 
95% confidence 
interval 
p-value 
Age 1.72 0.23, 3.20 0.024 
Weight -2.71 -5.51, 0.10 0.058 
Height 0.38 -1.90, 2.65 0.744 
Waist circumference 3.24 0.82, 5.66 0.009 
Knee pain lasting >1 month 26.24 5.73, 46.76 0.012 
Diabetes -12.18 -39.91, 15.54 0.387 
Arthritis 23.97 -5.82, 53.77 0.114 
Depressive symptoms 2.84 -1.69, 7.37 0.218 
Peripheral artery disease -7.43 -54.73, 39.87 0.757 
Use of walking aid 100.54 51.64, 149.44 <0.001 
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Table 43: Multivariate linear regression analyses of time to complete 400 meter walk (in seconds) for 
women 
Variables Beta coefficient 95% confidence 
interval 
p-value 
Age 0.82 -1.24, 2.88 0.431 
Weight -2.80 -5.33, -0.27 0.031 
Height -0.90 -3.36, 1.56 0.471 
Waist circumference 2.71 0.71, 4.72 0.008 
Knee pain lasting >1 month 37.50 12.06, 62.95 0.004 
Diabetes 12.32 -20.45, 45.09 0.459 
Arthritis -2.78 -34.39, 28.83 0.862 
Depressive symptoms 3.20 -0.40, 6.81 0.081 
Peripheral artery disease 16.05 -59.56, 91.66 0.675 
Use of walking aid 122.85 66.76, 178.94 <0.001 
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6.0 SUMMARY AND PUBLIC HEALTH SIGNIFICANCE 
 
We are living in a rapidly aging world. Almost all nations in the world are now experiencing a growth in 
the number of older adults. However, the most rapid increases in the older population are in the 
developing world. As a result, developing countries will have less time to adjust to the consequences of 
this change in population restructuring. Developing countries have not encountered such high numbers 
of older adults in their population and are not fully equipped to handle the challenges presented by this 
change. Additionally, population aging in developing countries is taking place at much lower levels of 
socioeconomic development compared to developed countries, leading to further complications.  
India is the second most populous country in the world with 1.21 billion people in its 2011 census, and 
has the second largest population of older adults. More than two-third of the elderly live in rural areas 
and suffer from several socioeconomic and health challenges. Less than 10% of the population has 
health insurance. Trends of a shift to an aging society will lead to increases in the burden of physical and 
cognitive disability and non-communicable diseases, notably osteoarthritis, cardiovascular disease (CVD) 
and diabetes. Indian health system is poorly equipped to address most of these issues associated with 
this dramatic change in demographics. There is dearth of health data on older adults in India, which is 
essential to analyze population aging and formulate mid- and long-term policies. 
The Mobility and Independent Living in Elders Study (MILES) was established to define the prevalence, 
incidence and risk factors for disability and age-related disease in rural older Indians. With this study we 
were able to fill several gaps in prior literature and made several observations for future directions. 
Analyses from MILES showed high prevalence of previously undiagnosed cardiovascular disease and risk 
factors. There was a clear relationship of some of the well-known risk factors for CVD with prevalent 
disease. Most of the estimates for global burden of disease, including CVD are from models filled by data 
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from developed countries. With growing prevalence of CVD in India, there is an urgent need to 
understand the burden of clinical as well as subclinical disease and risk factors using studies conducted 
in India. Strong public health policies are required to not only restrict use of smoking, but also chewing 
tobacco. Physical activity needs to be promoted, particularly among older adults. Improved access to 
health care and inexpensive, but effective medication is required to combat disease and risk factors, 
including hypertension. Better optimization of treatment is needed for management of diagnosed 
disease. Good incidence data is needed to have better understanding of disease processes in this 
population, particularly in women.  
The high prevalence of depressive symptoms observed among older adults indicates an urgent need, 
both for greater awareness of depression among community members and to ensure availability and 
accessibility of appropriate health care services to manage it. At the same time, it is important to 
increase community support and create networks for better geriatric care. These results suggest that 
prevention or reduction of depressed mood could play a role in reducing functional decline in older 
persons.  
Problems with vision were highly prevalent in both men and women. Improvement in vision is a very 
important modifiable risk factor for mobility disability and more effort is needed to provide access to 
corrective surgery and prosthetic aids to neglected and vulnerable populations. Increased screening for 
visual impairment can be an inexpensive, but very effective was tool to improve quality of life in this 
population.  
Timely detection of subclinical disease may allow for early treatment opportunities leading to improved 
survival and lowering disability in older population. Earlier diagnosis and better management of chronic 
conditions may delay the development of mobility disability and related morbidity. Risk factor 
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modification may not only prevent disability, but can also have an impact on improving quality of life in 
older adults.  
Mobility disability was highly prevalent in this population, particularly in women. Understanding the 
burden of mobility disability is crucial in this rapidly aging population. Mobility disability is shown to be 
risk factor for several geriatric conditions, including falls, fractures, cognitive decline, dementia and 
functional decline. Decreased mobility due to impaired mobility leads to further increase in health 
problems in older adults, including loss of muscle mass and strength, and deterioration of other chronic 
conditions, increasing the risk of institutionalization and death. Even though we could not attribute 
unidirectional causality between risk factors and mobility disability in this study, we were able to 
identify factors that were independently associated with mobility disability. 
There are several barriers for the mobility disabled population, particularly in developing countries. 
There are inadequate policies and standards for people with disabilities, or lack of enforcement of 
existing policies. These include lack of standards and policies for improving accessibility in physical 
environment and transport systems suitable for disabled, making this already neglected population 
more isolated. In persons identified as disabled, low priority is given to rehabilitation. Other issues, 
including negative attitudes toward disabled, lack of provision of services, lack of funding and last but 
not least, lack of data and evidence, further impeding understanding and action on these issues.  
More research using objective measures is urgently needed in older population in developing countries 
to estimate the burden of disease and disability with more certainty. Improvement in data quality is 
required by ensuring strict quality controls in research, expanding collaborative efforts and creating 
comparable data. Development of quality disability and disease data may be a long term effort, but it is 
required to provide essential support for better monitoring and development of strategies to improve 
functioning in this population.   
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MILES is a longitudinal study and we will continue to follow participants for a total of five years. This will 
provide valuable knowledge about incident disease, disability and mortality.    
125 
BIBLIOGRAPHY 
1. Gutman, G., Global aging: Key elements of the demographic transition. 2011.
2. World Population Ageing: 1950-2050. 2001, United Nations.
3. Kinsell, K. and W. He, An aging world: 2008. US Census Bureau, International Population 
Reports, 2009: p. 95.
4. Kapteyn, A., What can we learn from (and about) Global Aging? Demography, 2010. 47: p. 191-
209. 
5. Provisional Population Totals Paper 1 of 2011 India. 2012  [cited 2012 November 15]; Available
from: http://censusindia.gov.in/2011-prov-results/prov_results_paper1_india.html.
6. World Population Prospects: The 2012 Revision. 2013, United Nations: New York.
7. Bloom, D.E., D. Canning, and G. Fink, Implications of population ageing for economic growth.
Oxford Review of Economic Policy, 2010. 26(4): p. 583-612.
8. Yip, W. and A. Mahal, The health care systems of China and India: performance and future 
challenges. Health Affairs, 2008. 27(4): p. 921-932.
9. Bloom, D.E., et al., The contribution of population health and demographic change to economic 
growth in China and India. Journal of Comparative Economics, 2010. 38(1): p. 17-33.
10. Alam, M., Ageing, old age income security and reforms: An exploration of Indian situation.
Economic and Political Weekly, 2004: p. 3731-3740.
11. Arokiasamy, P., et al., Longitudinal aging study in India: vision, design, implementation, and 
some early results. 2011, Program on the Global Demography of Aging.
12. WHO, World Report on Disability. 2011.
13. Katherine Ritchey DO, M. and M. Stephanie Studenski MD, Epidemiology of Falls and Mobility
Disorders, in The Epidemiology of Aging. 2012, Springer. p. 293-316.
14. Statistics, N.C.f.H. Older Americans 2012: Key Indicators of Well-being. 2012. Federal Interagency
Forum on Aging Related Statistics. 
15. Guralnik, J.M., L.P. Fried, and M.E. Salive, Disability as a public health outcome in the aging 
population. Annual review of public health, 1996. 17(1): p. 25-46.
16. Studenski, S., et al., Gait speed and survival in older adults. JAMA, 2011. 305(1): p. 50-8.
17. Gill, T.M., et al., The dynamic nature of mobility disability in older persons. J Am Geriatr Soc,
2006. 54(2): p. 248-54.
18. Ferrucci, L., et al., Progressive versus catastrophic disability: a longitudinal view of the 
disablement process. The Journals of Gerontology Series A: Biological Sciences and Medical
Sciences, 1996. 51(3): p. M123-M130.
19. Newman, A.B. and J.A. Cauley, The Epidemiology of Aging: Aging, geriatric syndromes and 
common conditions. 2012: Springer.
20. Nagi, S., Some conceptual issues in disability and rehabilitation. Sociology and rehabilitation, 
1965. 
21. Ferrucci, L., et al., Subsystems contributing to the decline in ability to walk: bridging the 
gap between epidemiology and geriatric practice in the InCHIANTI study. Journal  of the 
American  Geriatrics  Society, 2000. 48(12): p. 1618-1625.
22. Brach, J., C. Rosano, and S. Studenski, Mobility. Hazzard's geriatric Medicine and Gerontology,
2009. 6: p. 1397-409.
23. Simonsick, E.M., et al., Mobility limitation in self-described well-functioning older adults:
importance of endurance walk testing. J Gerontol A Biol Sci Med Sci, 2008. 63(8): p. 841-7.
126 
24. Lang, T., et al., Sarcopenia: etiology, clinical consequences, intervention, and assessment.
Osteoporosis international, 2010. 21(4): p. 543-559.
25. Newman, A.B., et al., Strength, but not muscle mass, is associated with mortality in the health,
aging and body composition study cohort. J Gerontol A Biol Sci Med Sci, 2006. 61(1): p. 72-7.
26. Baumgartner, R.N., et al., Sarcopenic obesity predicts instrumental activities of daily living 
disability in the elderly. Obesity research, 2004. 12(12): p. 1995-2004.
27. Inzitari, M., Determinants of Mobility Disability in Older Adults: Evidence from Population-based
Epidemiologic Studies. Vol. 11. 2010: Firenze University Press.
28. Guralnik, J.M., et al., A short physical performance battery assessing lower extremity function:
association with self-reported disability and prediction of mortality and nursing home admission.
J Gerontol, 1994. 49(2): p. M85-94.
29. Simonsick, E.M., et al., Measuring higher level physical function in well-functioning older adults: 
expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci, 2001.
56(10): p. M644-9.
30. Inzitari, M., et al., Gait speed predicts decline in attention and psychomotor speed in older 
adults: the health aging and body composition study. Neuroepidemiology, 2007. 29(3-4): p. 156-
62.
31. Visser, M., D.J. Deeg, and P. Lips, Low vitamin D and high parathyroid hormone levels as 
determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging 
Study Amsterdam. Journal of Clinical Endocrinology & Metabolism, 2003. 88(12): p. 5766-5772.
32. Hofman, A., et al., Determinants of disease and disability in the elderly: the Rotterdam Elderly
Study. European journal of epidemiology, 1991. 7(4): p. 403-422.
33. Ensrud, K.E., et al., Correlates of impaired function in older women. Journal of the American 
Geriatrics Society, 1994.
34. Katz, S., et al., Progress in development of the index of ADL. The Gerontologist, 1970. 10(1 Part
1): p. 20-30.
35. Leon, J. and T.J. Lair, Functional status of the noninstitutionalized elderly: estimates of ADL and 
IADL difficulties. 1990: Department of Health & Human Services, Public Health Service, Agency
for Health Care Policy and Research.
36. Miller, M.E., et al., Physical activity, functional limitations, and disability in older adults. J Am
Geriatr Soc, 2000. 48(10): p. 1264-72.
37. Landi, F., et al., Physical activity prevented functional decline among frail community-living
elderly subjects in an international observational study. J Clin Epidemiol, 2007. 60(5): p. 518-24.
38. Rozzini, R., et al., The effect of chronic diseases on physical function. Comparison between
activities of daily living scales and the Physical Performance Test. Age Ageing, 1997. 26(4): p.
281-7.
39. Collin, C., et al., The Barthel ADL Index: a reliability study. Disability & Rehabilitation, 1988. 10(2):
p. 61-63.
40. Wade, D. and C. Collin, The Barthel ADL Index: a standard measure of physical disability?
Disability & Rehabilitation, 1988. 10(2): p. 64-67.
41. Haley, S.M., C.A. McHorney, and J.E. Ware Jr, Evaluation of the MOS SF-36 physical functioning 
scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. Journal of Clinical
Epidemiology, 1994. 47(6): p. 671-684.
42. Pahor, M., et al., Effects of a physical activity intervention on measures of physical performance:
Results of the lifestyle interventions and independence for Elders Pilot (LIFE-P) study. J Gerontol A
Biol Sci Med Sci, 2006. 61(11): p. 1157-65.
43. Guralnik, J.M., et al., Lower extremity function and subsequent disability consistency across
studies, predictive models, and value of gait Speed alone compared with the short physical 
127 
performance battery. The Journals of Gerontology Series A: Biological Sciences and Medical 
Sciences, 2000. 55(4): p. M221-M231. 
44. Guralnik, J.M., et al., Lower-extremity function in persons over the age of 70 years as a predictor 
of subsequent disability. N Engl J Med, 1995. 332(9): p. 556-61. 
45. Vasunilashorn, S., et al., Use of the Short Physical Performance Battery Score to predict loss of 
ability to walk 400 meters: analysis from the InCHIANTI study. The Journals of Gerontology 
Series A: Biological Sciences and Medical Sciences, 2009. 64(2): p. 223. 
46. Abellan van Kan, G., et al., Gait speed at usual pace as a predictor of adverse outcomes in 
community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task 
Force. The journal of nutrition, health & aging, 2009. 13(10): p. 881-9. 
47. Cesari, M., et al., Prognostic value of usual gait speed in well-functioning older people--results 
from the Health, Aging and Body Composition Study. J Am Geriatr Soc, 2005. 53(10): p. 1675-80. 
48. Marsh, A.P., et al., Lower extremity strength and power are associated with 400-meter walk time 
in older adults: The InCHIANTI study. The Journals of Gerontology Series A: Biological Sciences 
and Medical Sciences, 2006. 61(11): p. 1186-1193. 
49. Newman, A.B., et al., Association of long-distance corridor walk performance with mortality, 
cardiovascular disease, mobility limitation, and disability. JAMA, 2006. 295(17): p. 2018-26. 
50. Vestergaard, S., et al., Characteristics of 400-meter walk test performance and subsequent 
mortality in older adults. Rejuvenation research, 2009. 12(3): p. 177-184. 
51. Newman, A.B., et al., Association of long-distance corridor walk performance with mortality, 
cardiovascular disease, mobility limitation, and disability. Jama, 2006. 295(17): p. 2018-2026. 
52. Simonsick, E.M., E. Fan, and J.L. Fleg, Estimating cardiorespiratory fitness in well-functioning 
older adults: treadmill validation of the long distance corridor walk. Journal of the American 
Geriatrics Society, 2006. 54(1): p. 127-132. 
53. Simonsick, E.M., et al., Measuring fitness in healthy older adults: the Health ABC Long Distance 
Corridor Walk. Journal of the American Geriatrics Society, 2001. 49(11): p. 1544-1548. 
54. Newman, A.B., et al., Walking performance and cardiovascular response: associations with age 
and morbidity—the Health, Aging and Body Composition Study. The Journals of Gerontology 
Series A: Biological Sciences and Medical Sciences, 2003. 58(8): p. M715-M720. 
55. Bischoff, H.A., et al., Identifying a cut-off point for normal mobility: a comparison of the timed 
'up and go' test in community-dwelling and institutionalised elderly women. Age Ageing, 2003. 
32(3): p. 315-20. 
56. Hirvensalo, M., T. Rantanen, and E. Heikkinen, Mobility difficulties and physical activity as 
predictors of mortality and loss of independence in the community-living older population. J Am 
Geriatr Soc, 2000. 48(5): p. 493-8. 
57. Brach, J.S., et al., Physical activity and functional status in community-dwelling older women: a 
14-year prospective study. Arch Intern Med, 2003. 163(21): p. 2565-71. 
58. Cesari, M., et al., Added value of physical performance measures in predicting adverse health-
related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc, 
2009. 57(2): p. 251-9. 
59. Cesari, M., et al., Prognostic Value of Usual Gait Speed in Well-Functioning Older People—Results 
from the Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 
2005. 53(10): p. 1675-1680. 
60. Guralnik, J.M., et al., Lower-extremity function in persons over the age of 70 years as a predictor 
of subsequent disability. New England Journal of Medicine, 1995. 332(9): p. 556-562. 
61. Abellan Van Kan, G., et al., Gait speed at usual pace as a predictor of adverse outcomes in 
community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task 
Force. The journal of nutrition, health & aging, 2009. 13(10): p. 881-889. 
128 
62. Verghese, J., et al., Epidemiology of gait disorders in community-residing older adults. J Am 
Geriatr Soc, 2006. 54(2): p. 255-61.
63. Ministry of Statistics and Programme Implementation, G.o.I., Manual on Disability Statistics.
2012. 
64. Mitra, S. and U. Sambamoorthi, Disability estimates in India: what the Census and NSS tell us.
Economic and Political Weekly, 2006: p. 4022-4026.
65. Newman, A.B., et al., " Successful aging": effect of subclinical cardiovascular disease. Archives of
internal medicine, 2003. 163(19): p. 2315.
66. Touboul, P.J., et al., Mannheim carotid intima-media thickness consensus (2004–2006).
Cerebrovascular diseases, 2007. 23(1): p. 75-80.
67. McDermott, M.M.G., et al., Leg symptoms, the ankle-brachial index, and walking ability in 
patients with peripheral arterial disease. Journal of general internal medicine, 1999. 14(3): p.
173-181.
68. McDermott, M.M.G., et al., Gait alterations associated with walking impairment in people with 
peripheral arterial disease with and without intermittent claudication. Journal of the American 
Geriatrics Society, 2001. 49(6): p. 747-754.
69. Hirsch, A.T., et al., Peripheral arterial disease detection, awareness, and treatment in primary
care. JAMA: the journal of the American Medical Association, 2001. 286(11): p. 1317-1324.
70. Börsch-Supan, A., et al., Health, ageing and retirement in Europe: first results from the Survey of
Health, Ageing and Retirement in Europe. 2005: Mannheim Research Institute for the Economics
of Aging (MEA) Mannheim,, Germany.
71. Sankoh, O. and P. Byass, The INDEPTH Network: filling vital gaps in global epidemiology.
International journal of epidemiology, 2012. 41(3): p. 579-588.
72. Naidoo, N., et al., Ageing and adult health status in eight lower-income countries: the INDEPTH 
WHO-SAGE collaboration. Global health action, 2010: p. 11.
73. Lee, J., et al., Markers and Drivers: Cardiovascular Health of Middle-Age and Older Indians. 2011.
74. Rantanen, T., et al., Midlife hand grip strength as a predictor of old age disability. JAMA, 1999.
281(6): p. 558-60.
75. Miller, M.E., et al., Physical activity, functional limitations, and disability in older adults. Journal
of the American Geriatrics Society; Journal of the American Geriatrics Society, 2000.
76. Simonsick, E.M., J.D. Kasper, and C.L. Phillips, Physical disability and social interaction: factors
associated with low social contact and home confinement in disabled older women (The 
Women's Health and Aging Study). J Gerontol B Psychol Sci Soc Sci, 1998. 53(4): p. S209-17.
77. Cesari, M., et al., Added Value of Physical Performance Measures in Predicting Adverse Health-
Related Events: Results from the Health, Aging and Body Composition Study. Journal of the
American Geriatrics Society, 2009. 57(2): p. 251-259.
78. Newman, A.B., et al., Association of long-distance corridor walk performance with mortality,
cardiovascular disease, mobility limitation, and disability. JAMA: the journal of the American 
Medical Association, 2006. 295(17): p. 2018-2026.
79. Perera, S., et al., Magnitude and patterns of decline in health and function in 1 year affect 
subsequent 5-year survival. The Journals of Gerontology Series A: Biological Sciences and
Medical Sciences, 2005. 60(7): p. 894-900.
80. Montero-Odasso, M., et al., Gait velocity as a single predictor of adverse events in healthy
seniors aged 75 years and older. The Journals of Gerontology Series A: Biological Sciences and
Medical Sciences, 2005. 60(10): p. 1304-1309.
81. Kusneniwar, G.N., et al., Determinants of Infant Mortality in a Developing Region in Rural 
Andhra Pradesh.    National Journal of Integrated Research in Medicine, 2013. 4(4): p. 20-26.
129 
82. Tatineni, A., et al., Health metrics improve childhood immunisation coverage in a rural 
population of Andhra Pradesh. Indian journal of public health, 2009. 53(1): p. 41. 
83. Fried, L.P., et al., The Cardiovascular Health Study: design and rationale. Ann Epidemiol, 1991. 
1(3): p. 263-76. 
84. Orwoll, E., et al., Design and baseline characteristics of the osteoporotic fractures in men (MrOS) 
study--a large observational study of the determinants of fracture in older men. Contemp Clin 
Trials, 2005. 26(5): p. 569-85. 
85. Fielding, R.A., et al., The Lifestyle Interventions and Independence for Elders Study: design and 
methods. J Gerontol A Biol Sci Med Sci, 2011. 66(11): p. 1226-37. 
86. Rose, G.A., The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. 
Bull World Health Organ, 1962. 27: p. 645-58. 
87. Yesavage, J.A. and J.I. Sheikh, Geriatric Depression Scale (GDS) Recent Evidence and 
Development of a Shorter Version. Clinical gerontologist, 1986. 5(1-2): p. 165-173. 
88. Lenfant, C., et al., Seventh report of the Joint National Committee on the Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. 
Hypertension, 2003. 41(6): p. 1178-9. 
89. Furberg, C.D., et al., Major electrocardiographic abnormalities in persons aged 65 years and 
older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research 
Group. Am J Cardiol, 1992. 69(16): p. 1329-35. 
90. Newman, A.B., et al., Lower extremity arterial disease in elderly subjects with systolic 
hypertension. J Clin Epidemiol, 1991. 44(1): p. 15-20. 
91. Stein, J.H., et al., Use of carotid ultrasound to identify subclinical vascular disease and evaluate 
cardiovascular disease risk: a consensus statement from the American Society of 
Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for 
Vascular Medicine. J Am Soc Echocardiogr, 2008. 21(2): p. 93-111; quiz 189-90. 
92. Ganguli, M., et al., Cognitive test performance in a community-based nondemented elderly 
sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int 
Psychogeriatr, 1996. 8(4): p. 507-24. 
93. Sheu, Y., et al., Bone strength measured by peripheral quantitative computed tomography and 
the risk of nonvertebral fractures: the osteoporotic fractures in men (MrOS) study. Journal of 
Bone and Mineral Research, 2011. 26(1): p. 63-71. 
94. Kellegren, J. and J. Lawrence, Radiological assessment of osteoarthritis. Ann Rheum Dis, 1957. 
16: p. 494-501. 
95. Kellgren, J. and J. Lawrence, Atlas of standard radiographs: the epidemiology of chronic 
rheumatism. Vol. 2. 1963, Oxford: Blackwell. 
96. Strotmeyer, E.S., et al., The Relationship of Reduced Peripheral Nerve Function and Diabetes 
With Physical Performance in Older White and Black Adults The Health, Aging, and Body 
Composition (Health ABC) Study. Diabetes Care, 2008. 31(9): p. 1767-1772. 
97. Steptoe, A., et al., Cohort profile: the English longitudinal study of ageing. International journal 
of epidemiology, 2013. 42(6): p. 1640-1648. 
98. WHO, Global health risks: mortality and burden of disease attributable to selected major risks. 
2009: World Health Organization. 
99. WHO, World health statistics 2010. 2010: World Health Organization. 
100. Tunstall-Pedoe, H., Preventing Chronic Diseases. A Vital Investment: WHO Global Report. 
Geneva: World Health Organization, 2005. pp 200. CHF 30.00. ISBN 92 4 1563001. Also published 
on http://www. who. int/chp/chronic_disease_report/en. International Journal of Epidemiology, 
2006. 35(4): p. 1107-1107. 
130 
101. Lopez, A.D., et al., Global and regional burden of disease and risk factors, 2001: systematic 
analysis of population health data. The Lancet, 2006. 367(9524): p. 1747-1757. 
102. WHO, Disease and Injury Country Estimates, Health Statistics and Health Information System. 
2009. 
103. Subramanian, S. and G.D. Smith, Patterns, distribution, and determinants of under-and 
overnutrition: a population-based study of women in India. The American journal of clinical 
nutrition, 2006. 84(3): p. 633-640. 
104. Monteiro, C.A., et al., Socioeconomic status and obesity in adult populations of developing 
countries: a review. Bulletin of the World Health Organization, 2004. 82(12): p. 940-946. 
105. Newman, A.B., Peripheral arterial disease: insights from population studies of older adults. 
Journal of the American Geriatrics Society, 2000. 48(9): p. 1157-1162. 
106. Chow, C., et al., Cardiovascular disease and risk factors among 345 adults in rural India—the 
Andhra Pradesh Rural Health Initiative. International journal of cardiology, 2007. 116(2): p. 180-
185. 
107. Yusuf, S., et al., Global burden of cardiovascular diseases part II: variations in cardiovascular 
disease by specific ethnic groups and geographic regions and prevention strategies. Circulation, 
2001. 104(23): p. 2855-2864. 
108. Krishnan, M., Coronary heart disease and risk factors in India–On the brink of an epidemic? 
Indian heart journal, 2012. 64(4): p. 364. 
109. Kannel, W., The Framingham Study: historical insight on the impact of cardiovascular risk factors 
in men versus women. The journal of gender-specific medicine: JGSM: the official journal of the 
Partnership for Women's Health at Columbia, 2001. 5(2): p. 27-37. 
110. Newman, A.B., et al., Ankle-arm index as a marker of atherosclerosis in the Cardiovascular 
Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation, 1993. 
88(3): p. 837-845. 
111. Cesari, M., et al., Inflammatory markers and cardiovascular disease (the health, aging and body 
composition [health ABC] study). The American journal of cardiology, 2003. 92(5): p. 522-528. 
112. De Bacquer, D., et al., Prognostic value of ECG findings for total, cardiovascular disease, and 
coronary heart disease death in men and women. Heart, 1998. 80(6): p. 570-577. 
113. Auer, R., et al., Association of major and minor ECG abnormalities with coronary heart disease 
events. JAMA, 2012. 307(14): p. 1497-1505. 
114. Fowkes, F.G.R., et al., Comparison of global estimates of prevalence and risk factors for 
peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet, 2013. 
382(9901): p. 1329-1340. 
115. McDermott, M.M., et al., Functional decline in peripheral arterial disease: associations with the 
ankle brachial index and leg symptoms. Jama, 2004. 292(4): p. 453-461. 
116. Gupta, R., N. Gupta, and R. Khedar, Smokeless tobacco and cardiovascular disease in low and 
middle income countries. Indian heart journal, 2013. 65(4): p. 369-377. 
117. Joshi, R., et al., Prevalence of cardiovascular risk factors among rural population of elderly in 
Wardha district. Journal of cardiovascular disease research, 2013. 4(2): p. 140-146. 
118. Ikeda, N., et al., Control of hypertension with medication: a comparative analysis of national 
surveys in 20 countries. Bulletin of the World Health Organization, 2014. 92(1): p. 10. 
119. Li, J. and J. Siegrist, Physical activity and risk of cardiovascular disease—a meta-analysis of 
prospective cohort studies. International journal of environmental research and public health, 
2012. 9(2): p. 391-407. 
120. Yusuf, S. and M. McKee, Documenting the Global Burden of Cardiovascular Disease: A Major 
Achievement but Still Work in Progress. Circulation, 2014: p. CIRCULATIONAHA. 114.008302. 
131 
121. Lee, J. and J.P. Smith, The effect of health promotion on diagnosis and management of diabetes. 
Journal of epidemiology and community health, 2012. 66(4): p. 366-371. 
122. Ebrahim, S., et al., Tackling non-communicable diseases in low-and middle-income countries: is 
the evidence from high-income countries all we need? PLoS medicine, 2013. 10(1). 
123. Stuckler, D. and K. Siegel, Sick societies: responding to the global challenge of chronic disease. 
2011: Oxford University Press. 
124. Das, S., Situation analysis of the elderly in India. Report by: Central statistics office ministry of 
statistics and programme implementation. Government of India, 2011: p. 30-31. 
125. Jeyalakshmi, S., S. Chakrabarti, and N. Gupta, Situation analysis of the elderly in India. Central 
Statistics Office, Ministry of Statistics and Programme Implementation, Government of India 
document, 2011. 
126. Gupta, I. and D. Sankar, Health of the elderly in India: A multivariate analysis. 2002: Institute of 
Economic Growth. 
127. Sayers, S.P., et al., Use of Self-Report to Predict Ability to Walk 400 Meters in Mobility-Limited 
Older Adults. Journal of the American Geriatrics Society, 2004. 52(12): p. 2099-2103. 
128. D'ATH, P., et al., Screening, detection and management of depression in elderly primary care 
attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale 
(GDS15) and the development of short versions. Family Practice, 1994. 11(3): p. 260-266. 
129. Liebig, P.S. and S.I. Rajan, An Aging India: Perspectives, Prospects, and Policies. 2013: Taylor & 
Francis. 
130. Prakash, D.I.J., Aging, disability, and disabled older people in India. Journal of Aging & Social 
Policy, 2003. 15(2-3): p. 85-108. 
131. Kumar, V., Ageing in India--an overview. The Indian journal of medical research, 1997. 106: p. 
257-264. 
132. Dandekar, K., The elderly in India. 1996. 
133. Venkatarao, T., et al., Prevalence of disability and handicaps in geriatric population in rural South 
India. Indian journal of public health, 2005. 49(1): p. 11. 
134. Avlund, K., M. Vass, and C. Hendriksen, Onset of mobility disability among community-dwelling 
old men and women. The role of tiredness in daily activities. Age Ageing, 2003. 32(6): p. 579-84. 
135. Merrill, S.S., et al., Gender differences in the comparison of self-reported disability and 
performance measures. The Journals of Gerontology Series A: Biological Sciences and Medical 
Sciences, 1997. 52(1): p. M19-M26. 
136. Newman12, A.B. and J.S. Brach, Gender gap in longevity and disability in older persons. Health, 
1999(1). 
137. Tseng, L.A., et al., Body composition explains sex differential in physical performance among 
older adults. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 
2014. 69(1): p. 93-100. 
138. Rao, A.V., Psychiatry of old age in India. International Review of Psychiatry, 1993. 5(2-3): p. 165-
170. 
139. Nandi, P., et al., A study of psychiatric morbidity of the elderly population of a rural community in 
West Bengal. Indian Journal of Psychiatry, 1997. 39(2): p. 122. 
140. Venkoba Rao, A., National Task Force Study on Problems of the aged seeking psychiatric help. 
ICMR 1987. Mental health status of the elderly. ICMR Bulletin, 1996. 26(5). 
141. Penninx, B.W., et al., Depressive symptoms and physical decline in community-dwelling older 
persons. Jama, 1998. 279(21): p. 1720-1726. 
142. Penninx, B.W., et al., Exploring the effect of depression on physical disability: longitudinal 
evidence from the established populations for epidemiologic studies of the elderly. American 
Journal of Public Health, 1999. 89(9): p. 1346-1352. 
132 
143. Bruce, M.L., Depression and disability in late life: directions for future research. The American 
Journal of Geriatric Psychiatry, 2001. 9(2): p. 102-112. 
144. West, C.G., et al., Is vision function related to physical functional ability in older adults? Journal 
of the American Geriatrics Society, 2002. 50(1): p. 136-145. 
145. Cacciatore, F., et al., Disability and 6-year mortality in elderly population. Role of visual 
impairment. Aging clinical and experimental research, 2004. 16(5): p. 382-388. 
146. Chaudhry, S.I., et al., Geriatric impairments and disability: the cardiovascular health study. 
Journal of the American Geriatrics Society, 2010. 58(9): p. 1686-1692. 
147. Reddy, K.S., Cardiovascular diseases in the developing countries: dimensions, determinants, 
dynamics and directions for public health action. Public health nutrition, 2002. 5(1a): p. 231-237. 
148. Reddy, K.S. and S. Yusuf, Emerging epidemic of cardiovascular disease in developing countries. 
Circulation, 1998. 97(6): p. 596-601. 
149. Kwon, S., et al., What is a meaningful change in physical performance? Findings from a clinical 
trial in older adults (the LIFE-P study). JNHA-The Journal of Nutrition, Health and Aging, 2009. 
13(6): p. 538-544. 
 
133 
